<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Toxins (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Toxins (Basel)</journal-id><journal-id journal-id-type="pmc-domain-id">1577</journal-id><journal-id journal-id-type="pmc-domain">toxins</journal-id><journal-id journal-id-type="publisher-id">toxins</journal-id><journal-title-group><journal-title>Toxins</journal-title></journal-title-group><issn pub-type="epub">2072-6651</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12197389</article-id><article-id pub-id-type="pmcid-ver">PMC12197389.1</article-id><article-id pub-id-type="pmcaid">12197389</article-id><article-id pub-id-type="pmcaiid">12197389</article-id><article-id pub-id-type="pmid">40559842</article-id><article-id pub-id-type="doi">10.3390/toxins17060264</article-id><article-id pub-id-type="publisher-id">toxins-17-00264</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Unveiling the Neurotoxic Effects of Ochratoxin A and Its Impact on Neuroinflammation</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6510-0879</contrib-id><name name-style="western"><surname>Garc&#237;a-Esparza</surname><given-names initials="M&#xC1;">Mar&#237;a &#193;ngeles</given-names></name><xref rid="af1-toxins-17-00264" ref-type="aff">1</xref><xref rid="c1-toxins-17-00264" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7841-9838</contrib-id><name name-style="western"><surname>Mateo</surname><given-names initials="EM">Eva Mar&#237;a</given-names></name><xref rid="af2-toxins-17-00264" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Robles</surname><given-names initials="JA">Jos&#233; Antonio</given-names></name><xref rid="af3-toxins-17-00264" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Capoferri</surname><given-names initials="M">Michela</given-names></name><xref rid="af4-toxins-17-00264" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1404-4982</contrib-id><name name-style="western"><surname>Jim&#233;nez</surname><given-names initials="M">Misericordia</given-names></name><xref rid="af5-toxins-17-00264" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9144-5096</contrib-id><name name-style="western"><surname>Soria</surname><given-names initials="JM">Jos&#233; Miguel</given-names></name><xref rid="af3-toxins-17-00264" ref-type="aff">3</xref><xref rid="c1-toxins-17-00264" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-toxins-17-00264"><label>1</label>Department of Pharmacy, Cardenal Herrera University&#8212;CEU Universities, 46001 Valencia, Spain</aff><aff id="af2-toxins-17-00264"><label>2</label>Department of Microbiology and Ecology, School of Medicine and Dentistry, University of Valencia, 46001 Valencia, Spain; <email>eva.mateo@uv.es</email></aff><aff id="af3-toxins-17-00264"><label>3</label>Department of Biomedical Sciences, Cardenal Herrera University&#8212;CEU Universities, 46001 Valencia, Spain; <email>robles.el@uchceu.es</email></aff><aff id="af4-toxins-17-00264"><label>4</label>Departament of Animal Production and Animal Health, Veterinary Public Health and Food Science and Tecnnology, Cardenal Herrera University&#8212;CEU Universities, 46001 Valencia, Spain; <email>michela.capoferricapoferri@alumnos.uchceu.es</email></aff><aff id="af5-toxins-17-00264"><label>5</label>Department of Microbiology and Ecology, University of Valencia, 46100 Valencia, Spain; <email>misericordia.jimenez@uv.es</email></aff><author-notes><corresp id="c1-toxins-17-00264"><label>*</label>Correspondence: <email>maria.garcia2@uchceu.es</email> (M.&#193;.G.-E.); <email>jose.soria@uchceu.es</email> (J.M.S.)</corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2025</year></pub-date><volume>17</volume><issue>6</issue><issue-id pub-id-type="pmc-issue-id">491458</issue-id><elocation-id>264</elocation-id><history><date date-type="received"><day>29</day><month>4</month><year>2025</year></date><date date-type="rev-recd"><day>17</day><month>5</month><year>2025</year></date><date date-type="accepted"><day>21</day><month>5</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>23</day><month>05</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>26</day><month>06</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-06-27 15:25:35.070"><day>27</day><month>06</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="toxins-17-00264.pdf"/><abstract><p>Ochratoxin A (OTA), a toxic compound generated by <italic toggle="yes">Aspergillus</italic> and <italic toggle="yes">Penicillium</italic> fungi, is a common contaminant in different food and animal feed sources, thereby posing possible dangers to human well-being. Although OTA is widely recognized for its kidney-damaging properties, new findings have also indicated its potential to harm the nervous system. Current research trends have increasingly examined the part played by environmental poisons, such as mycotoxins, in the development of diseases. This systematic review gathers and assesses the features of OTA along with the insights acquired from studies on its neurotoxicity. This work presents recent research that demonstrates some mechanisms by which OTA crosses the intestinal and blood&#8211;brain barriers, penetrating neural structures. In addition, it discusses the effect of OTA on several types of neural cells and its roles in apoptosis, neuroinflammation, and neurogenesis defects, while also determining the effects of antioxidant systems that neutralize the effects of OTA. This paper identifies crucial gaps in the research and highlights the necessity for further in-depth studies into how OTA affects the processes underlying neurodegeneration. Filling these knowledge gaps could provide valuable insights into the neurotoxic potential of OTA and its relevance to neurological disorders.</p></abstract><kwd-group><kwd>inflammation</kwd><kwd>mycotoxins</kwd><kwd>nervous system</kwd><kwd>neurodegeneration</kwd><kwd>ochratoxin A</kwd></kwd-group><funding-group><award-group><funding-source>Programa de Investigaci&#243;n a Grupos de Investigaci&#243;n reconocidos GIR, CEU-UCH 2024&#8211;2025</funding-source><award-id>GIR 24/59</award-id><award-id>GIR 24/19</award-id></award-group><award-group><funding-source>Ministry of Science, Innovation and Universities (Spanish Government)</funding-source><award-id>PID2023-149211OB-C33</award-id></award-group><funding-statement>This research was funded by the Programa de Investigaci&#243;n a Grupos de Investigaci&#243;n reconocidos GIR, CEU-UCH 2024&#8211;2025 by the projects numbers GIR 24/59 and GIR 24/19. The authors acknowledge financial support from the Ministry of Science, Innovation and Universities (Spanish Government) through Project PID2023-149211OB-C33.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta><notes notes-type="Key Contribution"><title>Key Contribution</title><p>Ochratoxin A (OTA) is a toxic compound produced by certain fungi that contaminates food and feed products. Recent research shows OTA can cross biological barriers and affect neural cells; leading to cell death; inflammation; and impaired neurogenesis. This study is of interest in understanding the effect of OTA on the nervous system.</p></notes></front><body><sec sec-type="intro" id="sec1-toxins-17-00264"><title>1. Introduction</title><p>Mycotoxins represent the toxins with the highest probability of entering the human body owing to shifts in the natural environment or incorrect handling of food items. Such conditions can encourage their presence and dissemination across food crops and their derived products [<xref rid="B1-toxins-17-00264" ref-type="bibr">1</xref>] These toxins are secondary metabolites produced by fungi and can be poisonous to vertebrates through ingestion, inhalation, or dermal contact. Their presence in the food chain can arise from fungal infection of crops, either via direct human consumption or following their use as animal feed. Entry into the food supply through animal sources is most probable through meat, milk, or eggs [<xref rid="B1-toxins-17-00264" ref-type="bibr">1</xref>]. Crucially, the metabolism of mycotoxins that have been ingested can lead to their accumulation within various organs or tissues [<xref rid="B1-toxins-17-00264" ref-type="bibr">1</xref>,<xref rid="B2-toxins-17-00264" ref-type="bibr">2</xref>]. Prior to 1985, the Food and Agriculture Organization of the United Nations (FAO) estimated that roughly 25% of world cereal production is contaminated by mycotoxins [<xref rid="B3-toxins-17-00264" ref-type="bibr">3</xref>,<xref rid="B4-toxins-17-00264" ref-type="bibr">4</xref>]. Furthermore, other foodstuffs, including nuts, spices, fruits, and products derived from them can also be contaminated by these fungal metabolites.</p><p>Mycotoxin production in agricultural crops can occur at various points in the food chain, encompassing pre-harvest, harvest, drying, and storage. Importantly, inadequate agricultural and harvesting practices, and improper drying, handling, packaging, storage, and transport conditions all encourage fungal growth, thereby elevating the risk of mycotoxin production. Once food has undergone processing, further mycotoxin production is unlikely provided that food commodities are stored under conditions that prevent fungal contamination and mycotoxin bioproduction, particularly if the water activity of the product is sufficiently low to prevent mold growth and mycotoxin production, with the latter being key to the production of products free from mycotoxins [<xref rid="B2-toxins-17-00264" ref-type="bibr">2</xref>].</p><p>Epidemiological links between several mycotoxins and a diverse array of health issues, encompassing neurological and developmental effects, have been established in both animals and humans [<xref rid="B1-toxins-17-00264" ref-type="bibr">1</xref>,<xref rid="B5-toxins-17-00264" ref-type="bibr">5</xref>,<xref rid="B6-toxins-17-00264" ref-type="bibr">6</xref>,<xref rid="B7-toxins-17-00264" ref-type="bibr">7</xref>]. Mycotoxins are considered the most prevalent food-related external toxin capable of affecting the brain, with some also known to traverse the blood&#8211;brain barrier (BBB), thus permitting their accumulation in brain tissues where they disrupt the normal function of the central nervous system (CNS) [<xref rid="B8-toxins-17-00264" ref-type="bibr">8</xref>,<xref rid="B9-toxins-17-00264" ref-type="bibr">9</xref>,<xref rid="B10-toxins-17-00264" ref-type="bibr">10</xref>]. Moreover, the part played by mycotoxins in making individuals more susceptible to the inherent neurotoxicity of nerve diseases is gaining increased recognition among researchers. Of note, the Aflatoxin B1 (AFB1), Deoxynivalenol (DON), T-2 toxin (T-2), OTA, Fumonisin B1 (FB1), and 3-Nitropropionic acid (3-NPA) mycotoxins, which have strong affinity with brain tissues, can enter the systemic circulation both through consumption or skin contact, and some of their metabolites can easily cross the BBB to reach nerve cells via transportation proteins [<xref rid="B11-toxins-17-00264" ref-type="bibr">11</xref>,<xref rid="B12-toxins-17-00264" ref-type="bibr">12</xref>].</p><p>In this current study, we focused on the detrimental impact of mycotoxins in terms of human health, especially in the CNS. To this end, we focused on ochratoxins and in particular, ochratoxin A (OTA), as the main toxin with notable effects on the nervous system.</p><p>For this review, a bibliographic search was conducted by using PubMed, Science Direct, and Web of Science. Given the specificity of the toxin and its impact on the nervous system, no time limit has been established for the bibliography provided in this review.</p></sec><sec id="sec2-toxins-17-00264"><title>2. The Characteristics of Ochratoxin A and Its Relationship with the Nervous System</title><sec id="sec2dot1-toxins-17-00264"><title>2.1. Origin, Contamination, and Characteristics of Ochratoxin A</title><p>Many elements such as genetic makeup, typical physiological functions, the external environment, and the quality of food each play a role in human health. Nevertheless, numerous chemical dangers represent significant threats to our health [<xref rid="B13-toxins-17-00264" ref-type="bibr">13</xref>], with mycotoxins representing a significant category of such dangers. Humans are exposed to mycotoxins via various routes, such as the respiratory system, skin, and gastrointestinal tract, the latter constituting the primary route for long-term exposure [<xref rid="B14-toxins-17-00264" ref-type="bibr">14</xref>]. Mycotoxins can have damaging effects on a range of organs, such as the liver, kidney, and immune system; furthermore, they can induce cancer, disorders of the reproductive system, and other functional impairments. Notably, a growing body of evidence suggests that these toxins may contribute to human neurodegenerative conditions [<xref rid="B15-toxins-17-00264" ref-type="bibr">15</xref>,<xref rid="B16-toxins-17-00264" ref-type="bibr">16</xref>]. Several studies, both epidemiological and experimental, indicate that certain chemical contaminants present in food can cause harmful effects by targeting the CNS, specifically nerve cells and glial cells [<xref rid="B17-toxins-17-00264" ref-type="bibr">17</xref>,<xref rid="B18-toxins-17-00264" ref-type="bibr">18</xref>,<xref rid="B19-toxins-17-00264" ref-type="bibr">19</xref>]. Ochratoxins, a type of mycotoxin frequently produced by <italic toggle="yes">Aspergillus</italic> and <italic toggle="yes">Penicillium</italic> species as metabolic by-products [<xref rid="B20-toxins-17-00264" ref-type="bibr">20</xref>,<xref rid="B21-toxins-17-00264" ref-type="bibr">21</xref>], exist in three distinct forms: ochratoxin A, B, and C [<xref rid="B22-toxins-17-00264" ref-type="bibr">22</xref>], as illustrated in <xref rid="toxins-17-00264-f001" ref-type="fig">Figure 1</xref> and <xref rid="toxins-17-00264-f002" ref-type="fig">Figure 2</xref>.</p><p>OTA (C<sub>20</sub>H<sub>18</sub>C<sub>l</sub>NO<sub>6</sub>; molecular weight: 403.8) Ochratoxin A has been shown to be one of the most toxic forms compared to the other forms described [<xref rid="B23-toxins-17-00264" ref-type="bibr">23</xref>]. It presents as a white, odorless, heat-resistant (with a melting point of 168&#8211;173 &#176;C), solid crystalline substance exhibiting limited solubility in water [<xref rid="B22-toxins-17-00264" ref-type="bibr">22</xref>]. The production of OTA occurs in numerous common fungal molds and can be detected in cereals, coffee, grapes, and meat. Typically, the reported mean concentration of OTA varies between 0.1 and 100 nanograms per gram of plant-derived foodstuffs [<xref rid="B24-toxins-17-00264" ref-type="bibr">24</xref>]. Moreover, derivative products from wheat, oats, barley, rye, maize, rice, millet, sorghum, soybeans, broad beans or other beans, peas, alfalfa, sunflower, or pumpkin seeds, coconut, peanuts, and hay after silage process can exhibit OTA levels ten times higher (ranging from 1 to 100 ng/g) [<xref rid="B25-toxins-17-00264" ref-type="bibr">25</xref>]. In human and animal feed derived from animals such as pig blood products, pork meat and edible offal, chicken meat and offal, and dry-cured ham, OTA concentrations are reported to range from 0.1 to 1 ng/g [<xref rid="B25-toxins-17-00264" ref-type="bibr">25</xref>,<xref rid="B26-toxins-17-00264" ref-type="bibr">26</xref>].</p><p>The European Commission has established limits through Commission Regulation (EU) 2023/915. In the past years, regulation for mycotoxins has been changing a lot, and the last regulation was set in 2023 [<xref rid="B27-toxins-17-00264" ref-type="bibr">27</xref>]. Thus, The European Commission has established limits for the maximum permissible level of OTA in various food products, including unprocessed cereal grains (5.0 parts per billion), processed cereals (3.0 ppb), and beer and grape juice (2.0 ppb). Furthermore, the Joint FAO/World Health Organization (WHO) Expert Committee on Food Additives (JECFA)&#8212;a specialist organization offering scientific guidance to the Codex Alimentarius Commission&#8212;has repeatedly considered OTA (in 1991, 1995, 2001, and 2007), recently (2023) establishing a maximum limit of 5 &#956;g/kg in wheat, barley, and rye under the Codex General Standard for Contaminants and Toxins in Food and Feed [<xref rid="B27-toxins-17-00264" ref-type="bibr">27</xref>,<xref rid="B28-toxins-17-00264" ref-type="bibr">28</xref>].</p></sec><sec id="sec2dot2-toxins-17-00264"><title>2.2. The Toxicokinetics of Ochratoxin A</title><p>The uptake of OTA via the gastrointestinal tract facilitates its entry into the systemic circulation, enabling its subsequent detection in blood and various tissues, particularly in organs exhibiting high metabolic activity such as the kidney, liver, muscle, and fat [<xref rid="B29-toxins-17-00264" ref-type="bibr">29</xref>]. During its circulation, OTA exhibits a strong ability to bind with plasma proteins but its elimination half-life is prolonged, ranging from 72 to 120 h in pigs and reaching 840 h (35 days) in humans [<xref rid="B30-toxins-17-00264" ref-type="bibr">30</xref>,<xref rid="B31-toxins-17-00264" ref-type="bibr">31</xref>]. OTA has also been detected in milk secretions which constitutes a risk for newborns, directly affecting their growth and development [<xref rid="B32-toxins-17-00264" ref-type="bibr">32</xref>,<xref rid="B33-toxins-17-00264" ref-type="bibr">33</xref>,<xref rid="B34-toxins-17-00264" ref-type="bibr">34</xref>]. Both OTA and its metabolites are excreted via the kidneys and the hepatobiliary system.</p><p>The metabolism of OTA is varied and significantly dependent on the species. In contrast to other species, humans possess a comparatively limited metabolic capacity for OTA, with the most significant metabolic pathways including amide or lactone moiety hydrolysis to form ochratoxin alpha (OT&#945;) or open lactone OTA, respectively, hydroxylation to form hydroxylated derivatives (4-OH-OTA and 10-OH-OTA), and glutathione (GSH) conjugation reactions (<xref rid="toxins-17-00264-f003" ref-type="fig">Figure 3</xref>). All the metabolic products resulting from these reactions exhibit lower toxicity compared to OTA, with the exception of open lactone OTA [<xref rid="B35-toxins-17-00264" ref-type="bibr">35</xref>]. The main hepatic metabolites appear to be the epimers (4R and 4S)-OH-OTA, formed by the cytochrome P450 (CYP450) system [<xref rid="B36-toxins-17-00264" ref-type="bibr">36</xref>], with CYP450 enzymes also generate hydroxylated metabolites and other less prevalent metabolites, including OTA-quinones.</p><p>Nevertheless, contradictory findings have been reported concerning the involvement of biotransformation products in the harmful effects of OTA, with several studies suggesting that different biotransformation pathways contribute to OTA-induced cytotoxicity [<xref rid="B36-toxins-17-00264" ref-type="bibr">36</xref>]. Given that numerous studies are beginning to reveal the different implications of OTA derivatives in human health, it is important to understand the kinetics and characteristics of these different metabolites. Interestingly, some data propose that simultaneous exposure to structurally related mycotoxins, which induce DNA damage through entirely distinct mechanisms, may substantially elevate the risk of cancer in humans who consume mold-contaminated foods [<xref rid="B37-toxins-17-00264" ref-type="bibr">37</xref>].</p></sec></sec><sec id="sec3-toxins-17-00264"><title>3. Ochratoxin Crosses the Gastrointestinal and Blood&#8211;Brain Barrier</title><p>The gut lining constitutes a vital barrier composed of interconnected elements and serves as the primary defense mechanism against infection by impeding the movement of potentially damaging toxins, bacteria, and viruses from the intestinal lumen into the circulation. The function of this barrier relies on the dynamic interplay between the luminal microbiota, epithelial cells, and immune cells located in the lamina propria (LP). A single layer of epithelial cells covers the intestinal wall and is crucial for maintaining this physical barrier [<xref rid="B38-toxins-17-00264" ref-type="bibr">38</xref>]. Within this context, the gut lining is composed of four principal intestinal cell types: absorptive enterocytes, which form the majority of the cellular components; protective mucus-producing goblet cells; Paneth cells, which generate antimicrobial peptides (AMPs); and hormone-secreting enteroendocrine cells [<xref rid="B39-toxins-17-00264" ref-type="bibr">39</xref>].</p><p>Epithelial cells exhibit connections to one another in the basolateral-to-apical direction by way of interconnected protein contacts, known as apical junctional complexes. These complexes include desmosomes, adherens junctions (AJs), and tight junctions (TJs) [<xref rid="B40-toxins-17-00264" ref-type="bibr">40</xref>]. Molecules traverse this gut lining via transcellular and paracellular pathways, with the latter being controlled by TJs. Consequently, TJs selectively regulate the flow of nutrients and stimuli and are regarded as the principal factors determining intestinal paracellular permeability [<xref rid="B16-toxins-17-00264" ref-type="bibr">16</xref>,<xref rid="B41-toxins-17-00264" ref-type="bibr">41</xref>,<xref rid="B42-toxins-17-00264" ref-type="bibr">42</xref>].</p><p>As represented in <xref rid="toxins-17-00264-f004" ref-type="fig">Figure 4</xref>, the intestine is protected from external stimuli in four ways: through the formation of a physical barrier (a solitary layer of partially permeable epithelial cells); and a chemical barrier (a mucus layer made up of mucins and antimicrobial peptides secreted by goblet cells and Paneth cells, respectively); an immunological barrier (through immune cells in the lamina propria (LP) and secreted immune mediators such as cytokines and secretory immunoglobulin A); and a microbial barrier (commensal bacteria present in the intestinal lumen). In this model, adjacent epithelial cells are connected by TJs, multiprotein complexes that link adjacent epithelial cells near their apical edge. These complexes are comprised of various transmembrane proteins, including junctional adhesion molecules (JAMs), claudins, and occludin, all of which are linked to the actin cytoskeleton via zonula occludens (ZO) proteins [<xref rid="B43-toxins-17-00264" ref-type="bibr">43</xref>,<xref rid="B44-toxins-17-00264" ref-type="bibr">44</xref>,<xref rid="B45-toxins-17-00264" ref-type="bibr">45</xref>]. Where the gut barrier integrity is poor there is a heightened risk of systemic infection and nutritional deficiency [<xref rid="B46-toxins-17-00264" ref-type="bibr">46</xref>,<xref rid="B47-toxins-17-00264" ref-type="bibr">47</xref>].</p><p>TJs close off the luminal extremity of the intercellular space and restrict transport via this paracellular pathway to only relatively small water-soluble molecules; their permeability alters in response to various physiological and pathophysiological stimuli, including illness and injury [<xref rid="B48-toxins-17-00264" ref-type="bibr">48</xref>]. Moreover, it has also become clear that the integrity of the gut barrier is dependent on the presence of micronutrients within the gut. Thus, the gut can respond to signals generated by the presence of the different foods it processes. However, the particular dietary constituents required to maintain the gut barrier remain unidentified and the processes through which alterations in junctional permeability arise are not widely understood. Consequently, within this context, OTA presents a significant risk to the health of both humans and animals. Indeed, despite OTA being nephrotoxic, immunotoxic, and carcinogenic, its main site of action is the kidneys [<xref rid="B49-toxins-17-00264" ref-type="bibr">49</xref>], its initial interaction following ingestion occurs with the gut lining [<xref rid="B50-toxins-17-00264" ref-type="bibr">50</xref>].</p><p>To understand the effect of OTA on the intestinal barrier at the molecular and cellular levels, studies using Caco-2 cells (a well-established intestinal model cell line [<xref rid="B51-toxins-17-00264" ref-type="bibr">51</xref>] have indicated that this toxin does not destroy TJ complexes but rather, &#8216;loosens&#8217; them, thereby making the transit of smaller molecules through the paracellular pathway easier [<xref rid="B52-toxins-17-00264" ref-type="bibr">52</xref>]. Consequently, it has been proposed that OTA specifically impacts claudins rather than inducing substantial alterations in cells. One study demonstrated that exposing both the apical and basolateral surfaces to OTA led to increased gut permeability, reduced the expression of TJ proteins, and altered the TJ protein distribution pattern [<xref rid="B53-toxins-17-00264" ref-type="bibr">53</xref>]. These effects on TJ protein localization were confirmed through transmission electron microscopy [<xref rid="B54-toxins-17-00264" ref-type="bibr">54</xref>]. Therefore, in vitro treatment with OTA resulted in heightened cell permeability and disrupted microvilli and TJ proteins in various cell culture systems [<xref rid="B53-toxins-17-00264" ref-type="bibr">53</xref>]. Moreover, the detrimental effects of OTA on the structure of the intestine have also been documented in various in vivo models [<xref rid="B55-toxins-17-00264" ref-type="bibr">55</xref>]. All these observations indicate that when the intestine experiences short-term exposure to low concentrations of mycotoxins, inherent cellular mechanisms maintain the integrity of the physical gut barrier. However, prolonged damage that surpasses the capacity for self-regulation disrupts intestinal epithelial cells and TJ proteins, resulting in barrier compromise. Similarly, extended exposure of animals to low mycotoxin doses can also negatively impact gut health.</p><p>Once OTA traverses the gut barrier, it enters the bloodstream and therein, its route to the nervous system requires that it crosses the BBB, a permeability barrier situated between the bloodstream and cerebral endothelial cells. In most vertebrates, the BBB controls the interchange of compounds between the blood circulation and the brain. Furthermore, it protects neurons from changes in osmotic pressure and xenobiotics or potentially harmful endogenous compounds in the bloodstream. Three types of cells, which can also be referred to as a neurovascular unit, form the BBB: cerebral microvessels are comprised by endothelial cells that surround blood capillaries. Their primary role constitutes the essential foundation of the barrier by governing the entry of nutrients and the exit of potentially harmful substances [<xref rid="B56-toxins-17-00264" ref-type="bibr">56</xref>]. A basal lamina envelops this layer of endothelial cells, also housing pericytes within its structure. Extensions from astrocytes, known as end feet, are positioned on this basal lamina, almost completely encompassing it. Both pericytes and astrocytes perform a range of regulatory roles, influencing the impermeability of the endothelial barrier and the expression of proteins [<xref rid="B57-toxins-17-00264" ref-type="bibr">57</xref>,<xref rid="B58-toxins-17-00264" ref-type="bibr">58</xref>].</p><p>To uphold its principal barrier functions, its operation can be categorized into three characteristics. Firstly, the physical barrier is formed by TJs, which close the gaps between the endothelial cells and minimize paracellular diffusion. The transmembrane proteins that constitute TJs, such as occludins or claudins, are linked to the actin cytoskeleton, forming the physical barrier and accounting for the high trans-endothelial electrical resistance (above 1000 &#937;&#183;cm&#178;) of the BBB [<xref rid="B59-toxins-17-00264" ref-type="bibr">59</xref>]. Different dose-dependent studies both in vitro and in vivo have shown that ingestion of OTA generates brain damage at different levels [<xref rid="B5-toxins-17-00264" ref-type="bibr">5</xref>,<xref rid="B8-toxins-17-00264" ref-type="bibr">8</xref>,<xref rid="B60-toxins-17-00264" ref-type="bibr">60</xref>,<xref rid="B61-toxins-17-00264" ref-type="bibr">61</xref>,<xref rid="B62-toxins-17-00264" ref-type="bibr">62</xref>,<xref rid="B63-toxins-17-00264" ref-type="bibr">63</xref>,<xref rid="B64-toxins-17-00264" ref-type="bibr">64</xref>]. Indeed, the presence of OTA in the brain seems to suggest that it crosses the BBB where it then settles in different neural structures [<xref rid="B65-toxins-17-00264" ref-type="bibr">65</xref>].</p><p>An in vitro investigation into the effects of OTA on the BBB has employed Porcine Brain Capillary Endothelial Cells (pBCEC) to show that 10 &#181;M of OTA was cytotoxic while 1 &#181;M concentration weakened the barrier. In contrast, other toxins like OT&#945;, citrinin (CIT), or dihydrogencitrate (DHCIT) did not compromise BBB integrity or induce cytotoxic effects [<xref rid="B65-toxins-17-00264" ref-type="bibr">65</xref>]. Despite their molecular characteristics and significant fat solubility, the rates at which these four mycotoxins crossed the barrier, and their permeability were notably less than anticipated. This unexpected outcome can be explained by the action of efflux transport proteins, which actively moved substances back into the bloodstream or the apical compartment within this experimental setup [<xref rid="B65-toxins-17-00264" ref-type="bibr">65</xref>], which was the strongest contributor to OTA excretion from renal tissues. <xref rid="toxins-17-00264-f005" ref-type="fig">Figure 5</xref> shows the negative effects of OTA on the intestinal barrier and BBB. Although this knowledge is based on recently published studies, further work will still be required to reveal the mechanisms by which OTA is able to cross the BBB.</p></sec><sec id="sec4-toxins-17-00264"><title>4. Cellular Effects of Ochratoxin A: An Insight into the Nervous System</title><p>The differing toxic effects of OTA on humans and livestock have been recognized for a considerable time. However, in recent years, health agencies have allocated increased resources to researching food contamination by mycotoxins, especially by aflatoxins, fumonisin, OTA, patulin, trichothecenes, and zearalenone. The current European legislation CE n. 1881/2006 and n. 1126/2007 establish the maximum levels of mycotoxins allowed in human food but nevertheless, regulations regarding certain products still remain unclear [<xref rid="B67-toxins-17-00264" ref-type="bibr">67</xref>]. As already mentioned, these toxins have a range of harmful effects on human health; OTA is nephrotoxic, hepatotoxic, teratogenic, immunotoxic, neurotoxic, and tumorigenic [<xref rid="B5-toxins-17-00264" ref-type="bibr">5</xref>,<xref rid="B9-toxins-17-00264" ref-type="bibr">9</xref>,<xref rid="B19-toxins-17-00264" ref-type="bibr">19</xref>,<xref rid="B60-toxins-17-00264" ref-type="bibr">60</xref>,<xref rid="B61-toxins-17-00264" ref-type="bibr">61</xref>,<xref rid="B68-toxins-17-00264" ref-type="bibr">68</xref>].</p><p>Recent studies focused on the neurotoxicity of OTA have suggested it builds up in the brain resulting in oxidative stress and DNA damage in several brain areas and nerve cell populations [<xref rid="B5-toxins-17-00264" ref-type="bibr">5</xref>,<xref rid="B61-toxins-17-00264" ref-type="bibr">61</xref>,<xref rid="B69-toxins-17-00264" ref-type="bibr">69</xref>,<xref rid="B70-toxins-17-00264" ref-type="bibr">70</xref>]. In fact, the neurotoxicity of OTA has been shown to be most evident in the cerebellum, ventral mesencephalon, hippocampus, and striatum brain regions [<xref rid="B8-toxins-17-00264" ref-type="bibr">8</xref>,<xref rid="B64-toxins-17-00264" ref-type="bibr">64</xref>]. Indeed, the detrimental effect of OTA on the CNS is garnering increasing attention due to several laboratory and animal studies in which OTA exposure was linked to neurological and neurobehavioral impairments [<xref rid="B60-toxins-17-00264" ref-type="bibr">60</xref>,<xref rid="B61-toxins-17-00264" ref-type="bibr">61</xref>,<xref rid="B70-toxins-17-00264" ref-type="bibr">70</xref>]. Nevertheless, research into the effects of acute or chronic OTA exposure on the CNS remains limited, despite indications that developing nervous tissue is particularly vulnerable to its damaging effects [<xref rid="B71-toxins-17-00264" ref-type="bibr">71</xref>,<xref rid="B72-toxins-17-00264" ref-type="bibr">72</xref>,<xref rid="B73-toxins-17-00264" ref-type="bibr">73</xref>].</p><p>Different studies have indicated that OTA hinders the creation of new nerve cells in the hippocampus, both in living organisms and in laboratory settings, and this effect may be linked to problems with learning and memory [<xref rid="B8-toxins-17-00264" ref-type="bibr">8</xref>,<xref rid="B61-toxins-17-00264" ref-type="bibr">61</xref>,<xref rid="B69-toxins-17-00264" ref-type="bibr">69</xref>,<xref rid="B70-toxins-17-00264" ref-type="bibr">70</xref>]. In this context, exposure to low levels of OTA may produce delayed nerve-damaging effects, which could subsequently play a part in the development of neurodegenerative conditions [<xref rid="B8-toxins-17-00264" ref-type="bibr">8</xref>,<xref rid="B73-toxins-17-00264" ref-type="bibr">73</xref>]. These toxicological effects on the hippocampus add to other findings demonstrating the deleterious effects of OTA on cell proliferation and differentiation processes in fetal midbrain cell cultures [<xref rid="B74-toxins-17-00264" ref-type="bibr">74</xref>], the developing brain [<xref rid="B75-toxins-17-00264" ref-type="bibr">75</xref>], and nerve stem or progenitor cells in the adult hippocampus [<xref rid="B61-toxins-17-00264" ref-type="bibr">61</xref>,<xref rid="B70-toxins-17-00264" ref-type="bibr">70</xref>]. Furthermore, the harmful effect of OTA on the creation of new nerve cells in the hippocampal dental gyrus of adult mouse brains has also been documented. Indeed, intraperitoneal injection of male mice with 1&#8211;6 doses of OTA (3.5 mg/kg body weight) over three days led to a notable dose-dependent reduction in the length and number of astrocyte branches, glial fibrillary acidic protein (GFAP) expression, and quantity of astrocytes and young and mature neurons [<xref rid="B61-toxins-17-00264" ref-type="bibr">61</xref>].</p><p>Moreover, there have been reports on the effects of OTA exposure on other neurogenic parts of the brain such as the subventricular zone (SVZ). The latter has been investigated for its importance in adult neurogenesis and the replacement of neural populations during adult life. The laboratory and animal effects of OTA exposure on the SVZ and neural precursors taken from this neurogenic niche suggest that OTA could harm the survival, multiplication, and specialization of both developing and adult SVZ cells, depending on the amount of exposure [<xref rid="B5-toxins-17-00264" ref-type="bibr">5</xref>]. <xref rid="toxins-17-00264-f006" ref-type="fig">Figure 6</xref> describes the locations affected by OTA in rodent brains.</p><p>As noted earlier, a strong link exists between OTA, mutagenicity, carcinogenicity, and genotoxicity, although the precise processes involved are not yet clear. Reports on the genotoxic effects of OTA indicate that it results in the formation of DNA adducts, inhibits protein synthesis, perturbs cellular energy production, initiates oxidative stress, induces apoptosis, alters mitosis, causes cell cycle arrest, and interferes with cytokine pathways. All these processes are linked with kidney and liver damage, teratotoxicity, immunological toxicity, and neurotoxicity. Some studies have also reported a connection between OTA and mental health disorders. In this context, administering OTA activates various pathways including p38 mitogen-activated protein kinases (MAPK) and Jun N-terminal Kinases (JNK), causes Extracellular-Signal-Regulated Kinase (ERK) dysfunction, disrupts brain-derived neurotrophic factor (BDNF), is related to Tyrosine hydroxylase (TH) overexpression, and caspase-3 and 9 activation, as well as ERK-1/2 phosphorylation which ultimately leads to the progression of Alzheimer&#8217;s disease (AD) [<xref rid="B76-toxins-17-00264" ref-type="bibr">76</xref>].</p><p>Furthermore, perhaps because of the range of brain locations affected by OTA, different studies seem to show that it is involved in different psychiatric disorders, demonstrating a relationship between mycotoxins and the development of neuropsychiatric symptoms including brain fog, cognitive impairment, and headaches [<xref rid="B77-toxins-17-00264" ref-type="bibr">77</xref>,<xref rid="B78-toxins-17-00264" ref-type="bibr">78</xref>]. Research has also demonstrated that sub-chronic oral exposure to OTA elicited pathological phenotypes in mice like those observed in Parkinson&#8217;s disease (PD) [<xref rid="B73-toxins-17-00264" ref-type="bibr">73</xref>,<xref rid="B79-toxins-17-00264" ref-type="bibr">79</xref>,<xref rid="B80-toxins-17-00264" ref-type="bibr">80</xref>]. Likewise, various studies have outlined a potential role played by OTA in the disease processes of autism through epigenetic processes [<xref rid="B81-toxins-17-00264" ref-type="bibr">81</xref>]. In this context, the authors proposed that a gene&#8211;environment interaction might trigger autism spectrum disorder, with the epigenetic neurotoxic effects being triggered by OTA in children with a genetic predisposition [<xref rid="B81-toxins-17-00264" ref-type="bibr">81</xref>,<xref rid="B82-toxins-17-00264" ref-type="bibr">82</xref>]. The mechanisms responsible for neural tissue toxicity remain unclear, but studies in organs and tissues outside the nervous system have shown that it has a variety of functions, with its processes including the hindering of protein creation, mitochondrial damage, oxidative stress, and DNA damage.</p></sec><sec id="sec5-toxins-17-00264"><title>5. Ochratoxin A, Mitochondrial Impairment, and Oxidative Stress: The Development of Neurological Diseases with Fatal Outcomes</title><p>Numerous investigations have shown that oxidative stress is a key factor in the toxicity of OTA [<xref rid="B19-toxins-17-00264" ref-type="bibr">19</xref>,<xref rid="B68-toxins-17-00264" ref-type="bibr">68</xref>,<xref rid="B83-toxins-17-00264" ref-type="bibr">83</xref>,<xref rid="B84-toxins-17-00264" ref-type="bibr">84</xref>,<xref rid="B85-toxins-17-00264" ref-type="bibr">85</xref>,<xref rid="B86-toxins-17-00264" ref-type="bibr">86</xref>,<xref rid="B87-toxins-17-00264" ref-type="bibr">87</xref>]. Oxidative stress indicates an imbalance between the widespread presence of reactive oxygen species (ROS) and the capacity of a living system to readily neutralize reactive intermediates or repair the resulting damage. Disruptions in the normal redox balance of cells can lead to toxic effects through the creation of peroxides and free radicals that harm all cell constituents, including proteins, fats, and DNA [<xref rid="B84-toxins-17-00264" ref-type="bibr">84</xref>,<xref rid="B88-toxins-17-00264" ref-type="bibr">88</xref>,<xref rid="B89-toxins-17-00264" ref-type="bibr">89</xref>]. The brain is particularly susceptible to oxidative stress due to its high metabolic rate and oxygen usage, making it a significant element in the development of many nerve-related disorders.</p><p>Excess ROS, encompassing molecules such as superoxide and hydroxyl radicals and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), can harm vital biomolecules, setting off a sequence of events that leads to cellular malfunction and, ultimately, to nerve cell degeneration. Consequently, a range of nerve-related illnesses including AD, PD, amyotrophic lateral sclerosis (ALS), Huntington&#8217;s disease (HD), multiple sclerosis (MS), and ischemic stroke, are linked to oxidative stress [<xref rid="B89-toxins-17-00264" ref-type="bibr">89</xref>,<xref rid="B90-toxins-17-00264" ref-type="bibr">90</xref>]. Given this, neuroprotection is a proactive approach to securing the nervous system, encompassing the brain, spinal cord, and peripheral nerves, by preventing or limiting damage to nerve cells and other components; it mainly defends the CNS against injury from acute and progressive nerve degeneration conditions.</p><p>Oxidative stress affects cells via mitochondria, which generate 90% of cellular energy as adenosine triphosphate (ATP) and which also regulate calcium metabolism and regulate heat production. Poorly functioning mitochondria produce elevated levels of ROS and reactive nitrogen species (RNS) that, as previously stated, lead to the oxidative damage of biomolecules. The ROS generated by mitochondria includes superoxide anions, H<sub>2</sub>O<sub>2</sub>, and hydroxyl radicals, which are managed by enzymes including Mn-SOD and Cu/Zn-SOD. Peroxisomes, which contain catalases to decompose H<sub>2</sub>O<sub>2</sub>, also contribute to the production of ROS. Antioxidant systems like glutathione S transferase (GST) and thioredoxin (Trx) neutralize excessive ROS and RNS but nonetheless, persistent oxidative stress still contributes to aging and cancer [<xref rid="B91-toxins-17-00264" ref-type="bibr">91</xref>,<xref rid="B92-toxins-17-00264" ref-type="bibr">92</xref>].</p><p>Moreover, the generation of nitric oxide (NO) is a component of oxidative stress, stemming from inadequate equilibrium in the regulation of ROS and RNS. NO has a wide variety of functions including in nerve signaling and blood pressure control, but too much NO can harm cells [<xref rid="B93-toxins-17-00264" ref-type="bibr">93</xref>], influence apoptosis, and cause inflammation. Moreover, NO can cause the release of cytochrome c from mitochondria, activating the caspase-dependent cell death pathway and binding to cytochrome c oxidase, leading to mitochondrial dysfunction. NO synthesis from L-arginine by nitric oxide synthases (NOS) involves NOS isoforms, including nNOS, eNOS, iNOS, and mtNOS [<xref rid="B94-toxins-17-00264" ref-type="bibr">94</xref>]. When nitric oxide (NO) interacts with superoxide within mitochondria, it forms peroxynitrite, a substance implicated in the development of illnesses like stroke, heart disease, diabetes, inflammation, cancer, nerve degeneration conditions, and the aging process [<xref rid="B94-toxins-17-00264" ref-type="bibr">94</xref>]. In this way, oxidative stress plays a key part in the disease processes of dementia, with studies showing links between oxidative stress markers like malondialdehyde (MDA), glutathione peroxidase (GSH-Px), and protein carbonyls (PC) and cognitive decline, particularly in older individuals [<xref rid="B94-toxins-17-00264" ref-type="bibr">94</xref>].</p><p>In turn, mitochondrial impairment may be one of the major mechanisms of OTA toxicity. Mitochondria represent the main location within cells for oxidative phosphorylation and aerobic respiration, and they also control the production of ROS and the natural occurrence of apoptosis [<xref rid="B95-toxins-17-00264" ref-type="bibr">95</xref>,<xref rid="B96-toxins-17-00264" ref-type="bibr">96</xref>]. In addition, as already mentioned, poorly functioning mitochondria can trigger oxidative stress, which ultimately leads to cell death period. In this way, oxidative stress and apoptosis caused by OTA in human liver cancer cells might be explained by a loss of mitochondrial membrane potential (MMP) [<xref rid="B97-toxins-17-00264" ref-type="bibr">97</xref>]. In vitro experiments examining how OTA affects the membrane structure of rat liver mitochondria it has been observed that OTA reduced the respiratory control of the isolated mitochondria in a dose-dependent manner, inhibiting their electron transfer functions [<xref rid="B98-toxins-17-00264" ref-type="bibr">98</xref>].</p><p>Another recent study showed that exposure to OTA considerably lowered MMP in neural cells and, in particular, retinal ganglion cells (RGC-5) [<xref rid="B99-toxins-17-00264" ref-type="bibr">99</xref>]. These researchers observed that when RGC-5 cells were exposed to OTA, their mitochondria became shorter, with fewer elongated and more spherical ones being present, indicating that this toxin might lead to mitochondrial rupture and thus dysfunction. Moreover, a comparable investigation has also suggested that H<sub>2</sub>O<sub>2</sub> can cause a reduction in MMP, triggering apoptosis in RGC-5 cells [<xref rid="B100-toxins-17-00264" ref-type="bibr">100</xref>]. Furthermore, earlier work on glial cells indicated that OTA reduced cell multiplication, leading to G0/G1 cell cycle arrest. This was linked to a decrease in the expression of <italic toggle="yes">CCND1</italic>, <italic toggle="yes">CCNE1</italic>, <italic toggle="yes">CDK4</italic>, and <italic toggle="yes">MYC</italic>. OTA also triggered cell death in NHA-SV40LT cells by causing a loss of MMP and an increase in <italic toggle="yes">BAX</italic> and <italic toggle="yes">TP53</italic> levels. Consequently, OTA appears to cause neurotoxicity in human astrocytes by hindering cell growth and initiating cell death through mitochondrial pathways [<xref rid="B78-toxins-17-00264" ref-type="bibr">78</xref>].</p><p>While neurons and astrocytes are fundamental brain cells affected by the neurotoxic effects of OTA, recent studies have also revealed it has similar effects on microglia [<xref rid="B101-toxins-17-00264" ref-type="bibr">101</xref>]. Microglia are the principal neuroimmune cell type and perform three crucial roles: they function as sentinels that continuously detect alterations in their surroundings; housekeepers that maintain a healthy nerve environment and normal function; and neuroprotective defenders that respond to said changes. Microglia are involved in both neuroinflammation and neurodegeneration [<xref rid="B102-toxins-17-00264" ref-type="bibr">102</xref>], with the start or exacerbation of the latter resulting from imbalances in microglial function [<xref rid="B102-toxins-17-00264" ref-type="bibr">102</xref>,<xref rid="B103-toxins-17-00264" ref-type="bibr">103</xref>,<xref rid="B104-toxins-17-00264" ref-type="bibr">104</xref>].</p></sec><sec id="sec6-toxins-17-00264"><title>6. The Role of Ochratoxin A in Neuroinflammation</title><p>The part played by nerve inflammation as an initiator of nerve cell degeneration is clearly recognized, with a proven connection between neuronal inflammation and nerve cell loss in several nerve degeneration conditions [<xref rid="B105-toxins-17-00264" ref-type="bibr">105</xref>]. Neuroinflammation is a defense mechanism that initially protects the brain by removing or inhibiting a wide range of pathogens. The inflammatory response of the brain is triggered by the activation of microglial cells and astrocytes in response to various types of CNS injury, pathogens, or even neurotoxic insults. The outcome of neuroinflammation is determined by cellular interactions, inflammatory mediators, and trophic and/or cytotoxic signals. It also hinges on various other elements such as how strong and how long the harmful event lasts, the degree of initial nerve cell damage and glial response, and how developed the brain is. Consequently, depending on the situation, the neuroinflammatory response might encourage nerve protection, regrowth, or nerve cell degeneration [<xref rid="B106-toxins-17-00264" ref-type="bibr">106</xref>]. In the context of the above, glial cell response is seen as the key occurrence in brain inflammation and thus, has been employed as an initial indicator of nerve damage.</p><p>Neuroinflammation manifests as increased levels of pro-inflammatory cytokines, activation of macrophages (microglia), the movement of white blood cells from the body into the nervous system, and damage to nerve tissue [<xref rid="B107-toxins-17-00264" ref-type="bibr">107</xref>]. Microglia are cells specialized in day-to-day homeostatic functions, including correcting neuronal hyperactivity [<xref rid="B103-toxins-17-00264" ref-type="bibr">103</xref>], which participates in neural-circuit remodeling [<xref rid="B108-toxins-17-00264" ref-type="bibr">108</xref>], neurogenesis [<xref rid="B109-toxins-17-00264" ref-type="bibr">109</xref>], and control the composition of the CNS milieu [<xref rid="B110-toxins-17-00264" ref-type="bibr">110</xref>]. In response to stimuli such as pathogens, microglia secrete inflammation-promoting signaling molecules including interleukin (IL)-1b, IL-16, tumor necrosis factor (TNF)-&#945;, and chemokines. In turn, they can mediate the activation of pro-inflammatory astrocytes and consequently initiate a secondary inflammatory response. Although nerve inflammation serves as a nerve-protecting process, it is important to remember that when sustained, it can induce neurotoxicity and is related to neurodegeneration [<xref rid="B102-toxins-17-00264" ref-type="bibr">102</xref>]. Moreover, OTA exposure induces an inflammatory response in astrocytes and microglial cells which promotes morphological changes and increased expression of cytokines and stress proteins [<xref rid="B60-toxins-17-00264" ref-type="bibr">60</xref>,<xref rid="B111-toxins-17-00264" ref-type="bibr">111</xref>,<xref rid="B112-toxins-17-00264" ref-type="bibr">112</xref>].</p><sec id="sec6dot1-toxins-17-00264"><title>6.1. The Astrocyte-Specific Effects of Ochratoxin A</title><p>Astrocyte reactivity can be tracked by the increased production of glial fibrillary acidic protein (GFAP) [<xref rid="B113-toxins-17-00264" ref-type="bibr">113</xref>], a type III intermediate filament protein central to inflammatory processes that might also have a part in altering nerve cell survival or degeneration. Elevated GFAP production as an indicator of astrocyte response (also termed astrocytosis, astrogliosis, or the gliotic response), can be seen at both the mRNA and protein levels [<xref rid="B114-toxins-17-00264" ref-type="bibr">114</xref>,<xref rid="B115-toxins-17-00264" ref-type="bibr">115</xref>]. In aggregate cultures, the presence of OTA decreased GFAP immunoreactivity [<xref rid="B111-toxins-17-00264" ref-type="bibr">111</xref>] and GFAP expression, with GFAP mRNA and protein downregulation occurring as soon as 24 h post-treatment. OTA simultaneously caused the upregulation of vimentin, another intermediate filament protein, which can be co-expressed with GFAP in certain reactive astrocyte populations. Intriguingly, in brain cell cultures grown without serum and allowed to clump together, a reduction in GFAP production and an increase in vimentin mRNA levels were more noticeable in cells from older animals following treatment with very low concentrations of OTA below the cytotoxic level (10 nM and 20 nM) [<xref rid="B112-toxins-17-00264" ref-type="bibr">112</xref>].</p><p>The OTA-induced modulation of astrocyte response in aggregating brain cell cultures suggests that cytoskeletal changes may be central to this process. In support of this notion, cyclic AMP, which enhances <italic toggle="yes">GFAP</italic> expression, can partially counteract the decrease in <italic toggle="yes">GFAP</italic> and inflammatory marker upregulation brought about by OTA [<xref rid="B112-toxins-17-00264" ref-type="bibr">112</xref>]. In another experiment, histotypic rat brain cell cultures were simultaneously exposed to extremely low concentrations of OTA (2 nmol or 10 nmol) and two astrocyte-specific proteins, metallothioneins I and II (MTI/MTII, at 25 ng/mL each) for 10 days. At the 10 nM OTA exposure level, the authors reported a rapid decrease in MTI, MTII, and GFAP after 48 h up until day 10, suggesting that these astrocytic proteins could have a significant part to play in astrocyte&#8211;microglial communication and the upregulation of microglial activity [<xref rid="B114-toxins-17-00264" ref-type="bibr">114</xref>,<xref rid="B115-toxins-17-00264" ref-type="bibr">115</xref>]. In vivo, OTA produced dose-dependent morphological changes in astrocytes and in GFAP markers in the hippocampus of male C57BL/6 mice, with a cumulative 60% decrease in GFAP-positive cells after six doses of 3.5 mg OTA/kg administered intraperitoneally [<xref rid="B61-toxins-17-00264" ref-type="bibr">61</xref>].</p></sec><sec id="sec6dot2-toxins-17-00264"><title>6.2. Microglia Activation and the Effects of Ochratoxin A</title><p>OTA is thought to cross the BBB, but the mechanism of microglia activation therein still remains unknown, although it has been suggested that OTA-mediated neurotoxicity happens due to the activation of MAPK activation [<xref rid="B116-toxins-17-00264" ref-type="bibr">116</xref>,<xref rid="B117-toxins-17-00264" ref-type="bibr">117</xref>]. In mammals, MAPKs include c-Jun NH2-terminal kinase (JNK), p38 MAPK, and ERK. These enzymes are serine&#8211;threonine protein kinases that regulate various cellular activities including proliferation, differentiation, apoptosis and survival, inflammation, and innate immunity. Of note, compromised MAPK signaling pathways contribute to the pathology of several human diseases including cancer and neurodegenerative disorders such as AD, PD, and ALS. In particular, JNK and p38 MAPK signaling are activated by oxidative, genotoxic, and osmotic cell stress as well as by proinflammatory cytokines such as TNF-&#945; and IL-1&#946;. The p38 MAPK pathway contributes to neuroinflammation mediated by glial cells, including microglia and astrocytes [<xref rid="B118-toxins-17-00264" ref-type="bibr">118</xref>].</p><p>To elucidate if OTA activates MAPKs, particularly the ERK, JNK, and p38 pathways, a series of experiments were conducted in immortalized mouse microglial cells (BV-2 cells) with ERK, p38 MAPK, or JNK inhibitors at different OTA concentrations [50, 250, and 500 nM) over 24 h. The results showed that OTA activated microglia through ERK and p38 MAPK but not JNK. Furthermore, MAPK signaling has a vital part in microglial cell activation by regulating the production of inflammation-promoting agents [<xref rid="B119-toxins-17-00264" ref-type="bibr">119</xref>]. At the neuronal level, experiments with BV-2 cells have also shown that OTA directly affects the activation of the neuroinflammatory response in a dose-dependent manner, increasing IL-6 and TNF-&#945; levels after only 24 h of exposure at a concentration of 50&#8211;2000 nM [<xref rid="B119-toxins-17-00264" ref-type="bibr">119</xref>].</p><p>Similarly, recent studies in immortalized human microglia SV40 cells cultured at different OTA concentrations (0.1 nM&#8211;100 nM) showed that this toxin can stimulate microglia to release of IL-1&#946;, IL-18, and CXCL8 in a dose-dependent manner [<xref rid="B101-toxins-17-00264" ref-type="bibr">101</xref>]. An increase in IL-6 and TNF-&#945; has also been observed in vitro studies with the SH-SY5Y undifferentiated human neuroblastoma cell line when exposed to OTA (3.1&#8211;12.5 &#956;M) for 24&#8211;48 h, with a dose-dependent increase in the TNF-&#945; response after 48 h [<xref rid="B120-toxins-17-00264" ref-type="bibr">120</xref>], as also seen in 3D rat whole-brain aggregate cultures [<xref rid="B120-toxins-17-00264" ref-type="bibr">120</xref>,<xref rid="B121-toxins-17-00264" ref-type="bibr">121</xref>].</p></sec><sec id="sec6dot3-toxins-17-00264"><title>6.3. Oligodendrocyte Markers Affected by Ochratoxin A Exposure</title><p>Oligodendrocytes, which form the myelin sheath around nerve fibers, develop from oligodendrocyte precursor cells through tightly orchestrated processes of migration, proliferation, and differentiation [<xref rid="B122-toxins-17-00264" ref-type="bibr">122</xref>]. They provide electric insulation for CNS axons by creating the myelin sheath that enables saltatory conduction of nerve impulses, ensuring proper neuronal function. Given that axon myelination is an energy-consuming process associated with a high metabolic turnover, oligodendrocytes are especially vulnerable to cytotoxic and excitotoxic factors [<xref rid="B123-toxins-17-00264" ref-type="bibr">123</xref>].</p></sec></sec><sec id="sec7-toxins-17-00264"><title>7. From Ochratoxin A-Induced Neuroinflammation to the Development of Neurodegenerative Diseases</title><p>Neuroinflammation is the initial response by activated glial cells and neurons to shield the brain from harm, infections by microbes or blood poisoning, or exposure to toxins. However, inflammatory molecules secreted by microglia can weaken the BBB, permitting the entry of immune cells from the body which can activate and harm glial cells and neurons, thereby contributing to nerve degeneration processes [<xref rid="B124-toxins-17-00264" ref-type="bibr">124</xref>]. Thus, given the role of OTA in neuroinflammation, it is important to take a neurological perspective to evaluate how exposure to this toxin at different doses can affect neuronal viability and survival and lead to long-term neurodegeneration diseases. In this sense, astrocytes are crucial for neuron survival because they respond to and reabsorb neurotransmitter overload to end synaptic processes. The glutamate&#8211;glutamine cycle is the main metabolic pathway involved in coupling astrocytes and neurons.</p><p>Glutamate is the primary excitatory neurotransmitter in the mammalian CNS and can be neurotoxic, leading to nerve cell death [<xref rid="B125-toxins-17-00264" ref-type="bibr">125</xref>]. Astrocytes take in and neutralize glutamate using sodium-dependent excitatory amino acid transporters (EAATs) such as excitatory amino acid transporter 1 (EAAT1) or glutamate-aspartate transporter 1 (GLAST) and EAAT2 or glutamate transporter 1 (GLT1). Next, it is transformed into glutamine by astrocytes via glutamine synthetase (GS) and is extracellularly released to be reabsorbed by neurons. Thus, the clearance of excessive glutamate levels by astrocytes prevents excitotoxicity, functional impairment, and neuronal death. More recent findings have indicated that OTA influences how EAATs are positioned within the outer layer of primary astrocytes, thereby reducing GLT1 production and leading to an inability to effectively capture L-glutamate within the nervous system [<xref rid="B126-toxins-17-00264" ref-type="bibr">126</xref>]. Indeed, mice subcutaneously injected with OTA for 2 weeks (cumulative dose of 8 mg/kg using Alzet osmotic minipumps) exhibited striatal dopaminergic depletion [<xref rid="B73-toxins-17-00264" ref-type="bibr">73</xref>]. Similarly, male Balb/C albino mice orally exposed to OTA (0.21 and 0.5 mg/kg) showed motor impairment and dopaminergic system dysfunction, even up to 6 months after exposure [<xref rid="B79-toxins-17-00264" ref-type="bibr">79</xref>].</p><p>Nevertheless, further study of gene expression associated with neuronal survival and viability will be important to elucidate the effect of OTA and its implications in neurodegenerative diseases. Several genes such as cellular tumor protein (<italic toggle="yes">p53</italic>) and apoptosis regulator BAX (<italic toggle="yes">BAX</italic>) are upregulated in normal human astrocyte cells treated with OTA (0.5, 1, and 2 &#956;M) [<xref rid="B78-toxins-17-00264" ref-type="bibr">78</xref>]. In addition, dysfunctions of <italic toggle="yes">BDNF</italic>, which plays an important role in brain functions such as plasticity, memory, and cognition, have been associated with neurodegenerative diseases and other psychiatric disorders [<xref rid="B127-toxins-17-00264" ref-type="bibr">127</xref>]. Furthermore, microtubule-associated protein tau (<italic toggle="yes">MAPT</italic>) and tubulin polymerization-promoting protein (<italic toggle="yes">TPPP</italic>), which both have microtubule functions, have also been connected to nerve-degenerating conditions [<xref rid="B128-toxins-17-00264" ref-type="bibr">128</xref>]. The impact of OTA on neuronal survival and viability, specifically in the expression of <italic toggle="yes">MAPT</italic>, <italic toggle="yes">BAX</italic>, <italic toggle="yes">P53</italic>, <italic toggle="yes">BDNF</italic>, and <italic toggle="yes">TPPP</italic> as measured by RT-qPCR, was investigated in SH-SY5Y cells exposed to OTA (2 fM, 20 fM, 2 pM, or 1 &#181;M) over 1, 2, or 11 days. <italic toggle="yes">BDNF</italic> expression significantly reduced after 11 days at 2 pM and <italic toggle="yes">P53</italic>, <italic toggle="yes">BAX</italic>, and <italic toggle="yes">MAPT</italic> expression reduced after 1 and 2 days at 1 &#181;M, suggesting that <italic toggle="yes">BDNF</italic> expression was negatively affected at significantly higher doses, which could have implications for long-term neuronal health [<xref rid="B129-toxins-17-00264" ref-type="bibr">129</xref>].</p></sec><sec id="sec8-toxins-17-00264"><title>8. Role of Antioxidants in Neuroprotection</title><p>The CNS is highly susceptible to oxidative damage because of its elevated oxygen consumption, high lipid content, and relatively limited endogenous antioxidant defenses [<xref rid="B130-toxins-17-00264" ref-type="bibr">130</xref>]. Additionally, given that the human brain contains upwards of 86 billion neurons and 250&#8211;300 billion glial cells, it consumes over 20% of resting oxygen levels, thereby amplifying its vulnerability to oxidative stress [<xref rid="B131-toxins-17-00264" ref-type="bibr">131</xref>]. This stress plays a key role in neuroinflammation given that the excessive production of ROS and RNS further exacerbates neuronal damage [<xref rid="B132-toxins-17-00264" ref-type="bibr">132</xref>]. Antioxidants are essential in mitigating the harmful effects of ROS and RNS to counteract oxidative stress and modulate the inflammatory response. By scavenging free radicals, antioxidants help preserve cellular integrity, protect neuronal function, and prevent the amplification of neuroinflammation [<xref rid="B133-toxins-17-00264" ref-type="bibr">133</xref>].</p><p>The cellular antioxidant defense system, which shields tissues from oxidative injury, comprises both endogenous and exogenous antioxidants capable of neutralizing a wide range of harmful molecules. These defenses are categorized into enzymatic and non-enzymatic groups, including oxidative enzyme inhibitors, cofactors for antioxidant enzymes, ROS/RNS scavengers, and transition metal chelators, all working synergistically to reduce cellular stress and maintain homeostasis [<xref rid="B134-toxins-17-00264" ref-type="bibr">134</xref>]. Among the key endogenous antioxidants, GSH is a central player that acts as a primary defense mechanism against ROS and RNS inside neurons. By directly neutralizing harmful free radicals, GSH helps maintain the redox balance and prevents oxidative damage to cellular components such as proteins, lipids, and DNA [<xref rid="B135-toxins-17-00264" ref-type="bibr">135</xref>].</p><p>In this context, mycotoxins such as OTA have been shown to contribute to oxidative stress in the CNS by depleting intracellular GSH levels, thus exacerbating neuronal damage. Supplementation with GSH precursors such as N-acetylcysteine (NAC) can restore GSH levels, reducing lipid peroxidation, protein oxidation, and mitochondrial damage. Furthermore, GSH is crucial in detoxifying OTA through conjugation reactions facilitated by GSTs, thereby promoting OTA elimination and mitigating its toxic effects on neuronal cells [<xref rid="B136-toxins-17-00264" ref-type="bibr">136</xref>]. Additionally, antioxidant enzymes such as superoxide dismutase (SOD) and catalase are crucial because they catalyze the conversion of superoxide radicals and H<sub>2</sub>O<sub>2</sub> into less harmful molecules to prevent further oxidative damage [<xref rid="B137-toxins-17-00264" ref-type="bibr">137</xref>]. Together, these endogenous antioxidants work in concert to protect neurons from the damaging effects of oxidative stress and to support cellular homeostasis.</p><p>Exogenous antioxidants, including polyphenols, &#945;-tocopherol (vitamin E), ascorbic acid (vitamin C), and coenzyme Q10 (CoQ10) also significantly contribute to neuroprotection by helping to maintain neuronal health and reduce oxidative damage. Polyphenols represent the largest group of phytochemicals, with many of these compounds found in plant-based foods. Abundant in fruits, vegetables, and tea, polyphenols exhibit potent antioxidants and anti-inflammatory effects. These compounds play a crucial role in reducing oxidative damage and modulating the signaling pathways involved in inflammation. Hence, through their ability to interfere with biochemical pathways that regulate the inflammatory response and protect against oxidative stress, polyphenols contribute to the prevention of various chronic diseases associated with inflammation and cellular aging, including AD and PD [<xref rid="B138-toxins-17-00264" ref-type="bibr">138</xref>].</p><p>In turn, vitamin E, a potent lipid-soluble antioxidant, integrates into cellular membranes, providing protection against lipid peroxidation and preventing subsequent damage to neuronal structures. As a critical component of cellular defense mechanisms, Vitamin E neutralizes ROS and RNS in lipid-rich environments, thereby safeguarding the integrity of cellular membranes against oxidative damage [<xref rid="B139-toxins-17-00264" ref-type="bibr">139</xref>]. In the context of neurodegenerative diseases, its role in preserving the fluidity and functionality of neuronal membranes is pivotal, particularly in mitigating processes such as neuroinflammation, mitochondrial dysfunction, and synaptic loss. Indeed, given its multifaceted protective mechanisms, vitamin E has also been investigated for its potential therapeutic applications in the prevention and management of neurodegenerative conditions such as AD and PD [<xref rid="B140-toxins-17-00264" ref-type="bibr">140</xref>].</p><p>Vitamin C is a water-soluble antioxidant renowned for its ability to neutralize ROS, thereby safeguarding cellular components from oxidative damage. Beyond its direct antioxidative action, vitamin C contributes to the regeneration of other antioxidants, notably vitamin E, enhancing the overall antioxidant defense system. This synergistic interaction ensures a robust protective mechanism against oxidative stress and hence, provides protection against various neurodegenerative disorders [<xref rid="B141-toxins-17-00264" ref-type="bibr">141</xref>]. Furthermore, vitamin C serves as a cofactor for enzymes involved in the biosynthesis of neurotransmitters and collagen, underscoring its multifaceted role in maintaining neuronal health and structural integrity [<xref rid="B138-toxins-17-00264" ref-type="bibr">138</xref>].</p><p>CoQ10 plays a crucial role in mitochondrial bioenergetics, acting as an electron carrier in the mitochondrial electron transport chain while concurrently mitigating mitochondrial-derived oxidative stress. Beyond its primary function in ATP synthesis, CoQ10 exhibits potent neuroprotective properties by stabilizing mitochondrial membranes, reducing apoptotic signaling, and improving neuronal resilience against oxidative insults. Indeed, emerging evidence suggests that CoQ10 supplementation may ameliorate mitochondrial dysfunction and oxidative damage in nerve-degenerating conditions such as PD and AD [<xref rid="B139-toxins-17-00264" ref-type="bibr">139</xref>]. Clinical trials have investigated its efficacy in delaying disease progression, though the findings to date remain inconclusive because of the variability in bioavailability and doubts about optimal dosing regimens [<xref rid="B140-toxins-17-00264" ref-type="bibr">140</xref>].</p><p>In summary, recent studies suggest that while exogenous antioxidants offer potential neuroprotective benefits, their clinical efficacy in neurodegenerative diseases such as AD, PD, and ALS still requires further investigation [<xref rid="B141-toxins-17-00264" ref-type="bibr">141</xref>]. Nonetheless, together, these antioxidants reduce the overall burden of oxidative stress and help preserve neuronal function, highlighting their therapeutic potential in the prevention and treatment of neurodegenerative diseases. Further work is clearly warranted to clarify the exact mechanisms and clinical efficacy of antioxidant-based interventions, paving the way for novel neuroprotective strategies.</p></sec><sec sec-type="conclusions" id="sec9-toxins-17-00264"><title>9. Conclusions</title><p>Ochratoxins are toxic fungal metabolites present in a wide variety of foods and their by-products, including fruits, vegetables, cereals, meat, eggs, and dairy products, among others. The primary means of exposure to ochratoxins is oral and moreover, their ability to withstand elevated temperatures makes it difficult to eradicate them from the food supply. Among the different forms of ochratoxin, OTA is the most harmful; its metabolism generates hydroxylated derivatives (4-OH-OTA and 10-OH-OTA) and products conjugated with GSH as well as other derivates, which are all considered less toxic than OTA.</p><p>OTA has been described as nephrotoxic, hepatotoxic, teratogenic, and immunotoxic in several species and is neurotoxic and causes kidney and liver tumors both in animals and humans. In recent years, numerous research projects have aimed to determine the presence of OTA in various parts of the brain as well as its neurological effects. It has been shown that the main mechanisms of OTA action include the induction of oxidative stress, alteration of transcriptional regulation and cell signaling, inhibition of protein synthesis, interference with metabolic enzymes, cell cycle arrest, and the initiation of apoptosis. In this current review, we surveyed the cellular damage caused by OTA in different nervous system cell types. Thus, we described what is known about the neuroinflammatory effects of OTA in neurons, astrocytes, oligodendrocytes, and microglia.</p><p>Various in vitro and in vivo studies on OTA intake have demonstrated that this toxin can cross the BBB and generate damage at different levels of the brain in a dose-dependent manner. Perhaps because of the wide range of brain locations affected by OTA, its involvement in several different psychiatric disorders has also been demonstrated. However, despite these published data, further work will still be needed to completely explain the processes by which OTA crosses the BBB. In turn, here, we also discussed other studies suggesting that exogenous antioxidants may offer neuroprotective benefits. Nonetheless, their clinical efficacy in neurodegenerative diseases such as AD, PD, and ALS will still require further investigation. Together, these antioxidants reduce the overall burden of oxidative stress and help preserve neuronal function, thereby highlighting their therapeutic potential in the prevention and treatment of neurodegenerative diseases. Finally, more studies will be required to investigate ways of managing and reducing foods and animal feed contaminated with mycotoxins, safeguarding the health of people and animals, and lessening the associated financial losses.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, M.&#193;.G.-E., M.J. and J.M.S.; data curation, J.A.R. and E.M.M.; writing&#8212;original draft preparation, M.&#193;.G.-E. and J.M.S.; writing&#8212;review and editing, M.C., E.M.M., M.&#193;.G.-E. and J.M.S.; visualization, M.J., M.C. and J.A.R.; supervision, M.&#193;.G.-E., J.M.S. and M.J.; project administration, M.&#193;.G.-E. and J.M.S.; funding acquisition, M.&#193;.G.-E. and J.M.S. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>No new data were created or analyzed in this study.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-toxins-17-00264"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coffey</surname><given-names>R.</given-names></name><name name-style="western"><surname>Cummins</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ward</surname><given-names>S.</given-names></name></person-group><article-title>Exposure assessment of mycotoxins in dairy milk</article-title><source>Food Control</source><year>2009</year><volume>20</volume><fpage>239</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1016/j.foodcont.2008.05.011</pub-id></element-citation></ref><ref id="B2-toxins-17-00264"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ramos</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Cano-Sancho</surname><given-names>G.</given-names></name><name name-style="western"><surname>Sanchis</surname><given-names>V.</given-names></name></person-group><article-title>Mycotoxins: Occurrence, toxicology, and exposure assessment</article-title><source>Food Chem. Toxicol.</source><year>2013</year><volume>60</volume><fpage>218</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2013.07.047</pub-id><pub-id pub-id-type="pmid">23907020</pub-id></element-citation></ref><ref id="B3-toxins-17-00264"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rice</surname><given-names>L.G.</given-names></name><name name-style="western"><surname>Ross</surname><given-names>P.F.</given-names></name></person-group><article-title>Methods for Detection and Quantitation of Fumonisins in Corn, Cereal Products and Animal Excreta</article-title><source>J. Food Prot.</source><year>1994</year><volume>57</volume><fpage>536</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.4315/0362-028X-57.6.536</pub-id><pub-id pub-id-type="pmid">31121655</pub-id></element-citation></ref><ref id="B4-toxins-17-00264"><label>4.</label><element-citation publication-type="book"><person-group person-group-type="editor"><collab>Food and Agriculture Organization of the United Nations</collab><collab>World Health Organization</collab><collab>United Nations Environment Programme</collab></person-group><source>Report of the Joint FAO/WHO/UNEP Conference on Mycotoxins Held in Nairobi, 17&#8211;19 September 1977</source><comment>FAO food and nutrition paper</comment><publisher-name>Food and Agriculture Organization of the United Nations</publisher-name><publisher-loc>Rome, Italy</publisher-loc><year>1977</year><size units="pages">107p</size></element-citation></ref><ref id="B5-toxins-17-00264"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paradells</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rocamonde</surname><given-names>B.</given-names></name><name name-style="western"><surname>Llinares</surname><given-names>C.</given-names></name><name name-style="western"><surname>Herranz-P&#233;rez</surname><given-names>V.</given-names></name><name name-style="western"><surname>Jimenez</surname><given-names>M.</given-names></name><name name-style="western"><surname>Garcia-Verdugo</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Zipancic</surname><given-names>I.</given-names></name><name name-style="western"><surname>Soria</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Garcia-Esparza</surname><given-names>M.A.</given-names></name></person-group><article-title>Neurotoxic effects of ochratoxin A on the subventricular zone of adult mouse brain</article-title><source>J. Appl. Toxicol.</source><year>2015</year><volume>35</volume><fpage>737</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.1002/jat.3061</pub-id><pub-id pub-id-type="pmid">25256750</pub-id></element-citation></ref><ref id="B6-toxins-17-00264"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohta</surname><given-names>K.</given-names></name><name name-style="western"><surname>Maekawa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Katagiri</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ueta</surname><given-names>E.</given-names></name><name name-style="western"><surname>Naruse</surname><given-names>I.</given-names></name></person-group><article-title>Genetic susceptibility in the neural tube defects induced by ochratoxin A in the genetic arhinencephaly mouse, Pdn/Pdn</article-title><source>Congenit. Anom.</source><year>2006</year><volume>46</volume><fpage>144</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1111/j.1741-4520.2006.00117.x</pub-id><pub-id pub-id-type="pmid">16922921</pub-id></element-citation></ref><ref id="B7-toxins-17-00264"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Uetsuka</surname><given-names>K.</given-names></name></person-group><article-title>Mechanisms of mycotoxin-induced neurotoxicity through oxidative stress-associated pathways</article-title><source>Int. J. Mol. Sci.</source><year>2011</year><volume>12</volume><fpage>5213</fpage><lpage>5237</lpage><pub-id pub-id-type="doi">10.3390/ijms12085213</pub-id><pub-id pub-id-type="pmid">21954354</pub-id><pub-id pub-id-type="pmcid">PMC3179161</pub-id></element-citation></ref><ref id="B8-toxins-17-00264"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Belmadani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Steyn</surname><given-names>P.S.</given-names></name><name name-style="western"><surname>Tramu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Betbeder</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Baudrimont</surname><given-names>I.</given-names></name><name name-style="western"><surname>Creppy</surname><given-names>E.E.</given-names></name></person-group><article-title>Selective toxicity of ochratoxin A in primary cultures from different brain regions</article-title><source>Arch. Toxicol.</source><year>1999</year><volume>73</volume><fpage>108</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1007/s002040050594</pub-id><pub-id pub-id-type="pmid">10350191</pub-id></element-citation></ref><ref id="B9-toxins-17-00264"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bruinink</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rasonyi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sidler</surname><given-names>C.</given-names></name></person-group><article-title>Differences in neurotoxic effects of ochratoxin A, ochracin and ochratoxin-alpha in vitro</article-title><source>Nat. Toxins</source><year>1998</year><volume>6</volume><fpage>173</fpage><lpage>177</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1522-7189(199809/10)6:5&amp;#x0003c;173::AID-NT10&amp;#x0003e;3.0.CO;2-4</pub-id><pub-id pub-id-type="pmid">10398513</pub-id></element-citation></ref><ref id="B10-toxins-17-00264"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>You</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Chrienova</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Nepovimova</surname><given-names>E.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Kuca</surname><given-names>K.</given-names></name></person-group><article-title>The neurotoxicity of trichothecenes T-2 toxin and deoxynivalenol (DON): Current status and future perspectives</article-title><source>Food Chem. Toxicol.</source><year>2020</year><volume>145</volume><fpage>111676</fpage><pub-id pub-id-type="doi">10.1016/j.fct.2020.111676</pub-id><pub-id pub-id-type="pmid">32805342</pub-id></element-citation></ref><ref id="B11-toxins-17-00264"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ravindran</surname><given-names>J.</given-names></name><name name-style="western"><surname>Agrawal</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>N.</given-names></name><name name-style="western"><surname>Rao</surname><given-names>P.V.L.</given-names></name></person-group><article-title>Alteration of blood brain barrier permeability by T-2 toxin: Role of MMP-9 and inflammatory cytokines</article-title><source>Toxicology</source><year>2011</year><volume>280</volume><fpage>44</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.tox.2010.11.006</pub-id><pub-id pub-id-type="pmid">21112371</pub-id></element-citation></ref><ref id="B12-toxins-17-00264"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weidner</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lenczyk</surname><given-names>M.</given-names></name><name name-style="western"><surname>Schwerdt</surname><given-names>G.</given-names></name><name name-style="western"><surname>Gekle</surname><given-names>M.</given-names></name><name name-style="western"><surname>Humpf</surname><given-names>H.-U.</given-names></name></person-group><article-title>Neurotoxic potential and cellular uptake of T-2 toxin in human astrocytes in primary culture</article-title><source>Chem. Res. Toxicol.</source><year>2013</year><volume>26</volume><fpage>347</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1021/tx3004664</pub-id><pub-id pub-id-type="pmid">23363530</pub-id></element-citation></ref><ref id="B13-toxins-17-00264"><label>13.</label><element-citation publication-type="webpage"><article-title>Emerging Fusarium and Alternaria Mycotoxins: Occurrence, Toxicity and Toxicokinetics</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.mdpi.com/2072-6651/9/7/228" ext-link-type="uri">https://www.mdpi.com/2072-6651/9/7/228</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-12-03">(accessed on 3 December 2024)</date-in-citation><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/toxins9070228</pub-id><pub-id pub-id-type="pmcid">PMC5535175</pub-id><pub-id pub-id-type="pmid">28718805</pub-id></element-citation></ref><ref id="B14-toxins-17-00264"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Turner</surname><given-names>P.C.</given-names></name><name name-style="western"><surname>Flannery</surname><given-names>B.</given-names></name><name name-style="western"><surname>Isitt</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pestka</surname><given-names>J.</given-names></name></person-group><article-title>The role of biomarkers in evaluating human health concerns from fungal contaminants in food</article-title><source>Nutr. Res. Rev.</source><year>2012</year><volume>25</volume><fpage>162</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1017/S095442241200008X</pub-id><pub-id pub-id-type="pmid">22651937</pub-id></element-citation></ref><ref id="B15-toxins-17-00264"><label>15.</label><element-citation publication-type="webpage"><article-title>Mycotoxins: Emerging Toxic Mechanisms, and Unanswered Research Questions&#8212;ScienceDirect</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.sciencedirect.com/science/article/abs/pii/S0278691523000753?via%3Dihub" ext-link-type="uri">https://www.sciencedirect.com/science/article/abs/pii/S0278691523000753?via%3Dihub</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-12-03">(accessed on 3 December 2024)</date-in-citation></element-citation></ref><ref id="B16-toxins-17-00264"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>V.T.T.</given-names></name><name name-style="western"><surname>K&#246;nig</surname><given-names>S.</given-names></name><name name-style="western"><surname>Eggert</surname><given-names>S.</given-names></name><name name-style="western"><surname>Endres</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kins</surname><given-names>S.</given-names></name></person-group><article-title>The role of mycotoxins in neurodegenerative diseases: Current state of the art and future perspectives of research</article-title><source>Biol. Chem.</source><year>2022</year><volume>403</volume><fpage>3</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1515/hsz-2021-0214</pub-id><pub-id pub-id-type="pmid">34449171</pub-id></element-citation></ref><ref id="B17-toxins-17-00264"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ke</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sidoryk-Wegrzynowicz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pajarillo</surname><given-names>E.</given-names></name><name name-style="western"><surname>Rizor</surname><given-names>A.</given-names></name><name name-style="western"><surname>Soares</surname><given-names>F.A.A.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>E.</given-names></name><name name-style="western"><surname>Aschner</surname><given-names>M.</given-names></name></person-group><article-title>Role of Astrocytes in Manganese Neurotoxicity Revisited</article-title><source>Neurochem. Res.</source><year>2019</year><volume>44</volume><fpage>2449</fpage><lpage>2459</lpage><pub-id pub-id-type="doi">10.1007/s11064-019-02881-7</pub-id><pub-id pub-id-type="pmid">31571097</pub-id><pub-id pub-id-type="pmcid">PMC7757856</pub-id></element-citation></ref><ref id="B18-toxins-17-00264"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osemwegie</surname><given-names>O.</given-names></name><name name-style="western"><surname>Ramkumar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>E.E.</given-names></name></person-group><article-title>Neurodegenerative Implications of Neuronal Cytoplasmic Protein Dysfunction in Response to Environmental Contaminants</article-title><source>Neurotox. Res.</source><year>2021</year><volume>39</volume><fpage>533</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1007/s12640-020-00308-8</pub-id><pub-id pub-id-type="pmid">33175324</pub-id></element-citation></ref><ref id="B19-toxins-17-00264"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Awogbindin</surname><given-names>I.O.</given-names></name><name name-style="western"><surname>Ikeji</surname><given-names>C.N.</given-names></name><name name-style="western"><surname>Adedara</surname><given-names>I.A.</given-names></name><name name-style="western"><surname>Farombi</surname><given-names>E.O.</given-names></name></person-group><article-title>Neurotoxicity of furan in juvenile Wistar rats involves behavioral defects, microgliosis, astrogliosis and oxidative stress</article-title><source>Food Chem. Toxicol.</source><year>2023</year><volume>178</volume><fpage>113934</fpage><pub-id pub-id-type="doi">10.1016/j.fct.2023.113934</pub-id><pub-id pub-id-type="pmid">37423315</pub-id></element-citation></ref><ref id="B20-toxins-17-00264"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bragulat</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Mart&#237;nez</surname><given-names>E.</given-names></name><name name-style="western"><surname>Castell&#225;</surname><given-names>G.</given-names></name><name name-style="western"><surname>Caba&#241;es</surname><given-names>F.J.</given-names></name></person-group><article-title>Ochratoxin A and citrinin producing species of the genus Penicillium from feedstuffs</article-title><source>Int. J. Food Microbiol.</source><year>2008</year><volume>126</volume><fpage>43</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2008.04.034</pub-id><pub-id pub-id-type="pmid">18571755</pub-id></element-citation></ref><ref id="B21-toxins-17-00264"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kabak</surname><given-names>B.</given-names></name><name name-style="western"><surname>Dobson</surname><given-names>A.D.W.</given-names></name><name name-style="western"><surname>Var</surname><given-names>I.</given-names></name></person-group><article-title>Strategies to prevent mycotoxin contamination of food and animal feed: A review</article-title><source>Crit. Rev. Food Sci. Nutr.</source><year>2006</year><volume>46</volume><fpage>593</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1080/10408390500436185</pub-id><pub-id pub-id-type="pmid">17092826</pub-id></element-citation></ref><ref id="B22-toxins-17-00264"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>X.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Broad-Specificity Immunoassay for Simultaneous Detection of Ochratoxins A, B, and C in Millet and Maize</article-title><source>J. Agric. Food Chem.</source><year>2017</year><volume>65</volume><fpage>4830</fpage><lpage>4838</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.7b00770</pub-id><pub-id pub-id-type="pmid">28535353</pub-id></element-citation></ref><ref id="B23-toxins-17-00264"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>P.</given-names></name><name name-style="western"><surname>Mahato</surname><given-names>D.K.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>B.</given-names></name><name name-style="western"><surname>Borah</surname><given-names>R.</given-names></name><name name-style="western"><surname>Haque</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mahmud</surname><given-names>M.M.C.</given-names></name><name name-style="western"><surname>Shah</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Rawal</surname><given-names>D.</given-names></name><name name-style="western"><surname>Bora</surname><given-names>H.</given-names></name><name name-style="western"><surname>Bui</surname><given-names>S.</given-names></name></person-group><article-title>Ochratoxins in food and feed: Occurrence and its impact on human health and management strategies</article-title><source>Toxicon</source><year>2020</year><volume>187</volume><fpage>151</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2020.08.031</pub-id><pub-id pub-id-type="pmid">32889024</pub-id></element-citation></ref><ref id="B24-toxins-17-00264"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ding</surname><given-names>L.</given-names></name><name name-style="western"><surname>Han</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y.</given-names></name></person-group><article-title>Ochratoxin A: Overview of Prevention, Removal, and Detoxification Methods</article-title><source>Toxins</source><year>2023</year><volume>15</volume><elocation-id>565</elocation-id><pub-id pub-id-type="doi">10.3390/toxins15090565</pub-id><pub-id pub-id-type="pmid">37755991</pub-id><pub-id pub-id-type="pmcid">PMC10534725</pub-id></element-citation></ref><ref id="B25-toxins-17-00264"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>S.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>D.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>D.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Ochratoxin A: Toxicity, oxidative stress and metabolism</article-title><source>Food Chem. Toxicol.</source><year>2018</year><volume>112</volume><fpage>320</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2018.01.002</pub-id><pub-id pub-id-type="pmid">29309824</pub-id></element-citation></ref><ref id="B26-toxins-17-00264"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ostry</surname><given-names>V.</given-names></name><name name-style="western"><surname>Malir</surname><given-names>F.</given-names></name><name name-style="western"><surname>Dofkova</surname><given-names>M.</given-names></name><name name-style="western"><surname>Skarkova</surname><given-names>J.</given-names></name><name name-style="western"><surname>Pfohl-Leszkowicz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ruprich</surname><given-names>J.</given-names></name></person-group><article-title>Ochratoxin A Dietary Exposure of Ten Population Groups in the Czech Republic: Comparison with Data over the World</article-title><source>Toxins</source><year>2015</year><volume>7</volume><fpage>3608</fpage><lpage>3635</lpage><pub-id pub-id-type="doi">10.3390/toxins7093608</pub-id><pub-id pub-id-type="pmid">26378578</pub-id><pub-id pub-id-type="pmcid">PMC4591665</pub-id></element-citation></ref><ref id="B27-toxins-17-00264"><label>27.</label><element-citation publication-type="webpage"><article-title>EU 2023/915</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32023R0915" ext-link-type="uri">https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32023R0915</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-05-17">(accessed on 17 May 2025)</date-in-citation></element-citation></ref><ref id="B28-toxins-17-00264"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malir</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ostry</surname><given-names>V.</given-names></name><name name-style="western"><surname>Pfohl-Leszkowicz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Malir</surname><given-names>J.</given-names></name><name name-style="western"><surname>Toman</surname><given-names>J.</given-names></name></person-group><article-title>Ochratoxin A: 50 Years of Research</article-title><source>Toxins</source><year>2016</year><volume>8</volume><elocation-id>191</elocation-id><pub-id pub-id-type="doi">10.3390/toxins8070191</pub-id><pub-id pub-id-type="pmid">27384585</pub-id><pub-id pub-id-type="pmcid">PMC4963825</pub-id></element-citation></ref><ref id="B29-toxins-17-00264"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ravelo Abreu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rubio Armend&#225;riz</surname><given-names>C.</given-names></name><name name-style="western"><surname>Guti&#233;rrez Fern&#225;ndez</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Hardisson de la Torre</surname><given-names>A.</given-names></name></person-group><article-title>La ocratoxina A en alimentos de consumo humano: Revisi&#243;n</article-title><source>Nutr. Hosp.</source><year>2011</year><volume>26</volume><fpage>1215</fpage><lpage>1226</lpage><pub-id pub-id-type="pmid">22411363</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1590/S0212-16112011000600004</pub-id></element-citation></ref><ref id="B30-toxins-17-00264"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Studer-Rohr</surname><given-names>I.</given-names></name><name name-style="western"><surname>Schlatter</surname><given-names>J.</given-names></name><name name-style="western"><surname>Dietrich</surname><given-names>D.R.</given-names></name></person-group><article-title>Kinetic parameters and intraindividual fluctuations of ochratoxin A plasma levels in humans</article-title><source>Arch. Toxicol.</source><year>2000</year><volume>74</volume><fpage>499</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1007/s002040000157</pub-id><pub-id pub-id-type="pmid">11131029</pub-id></element-citation></ref><ref id="B31-toxins-17-00264"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stojkovi&#263;</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hult</surname><given-names>K.</given-names></name><name name-style="western"><surname>Gamulin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Plestina</surname><given-names>R.</given-names></name></person-group><article-title>High affinity binding of ochratoxin A to plasma constituents</article-title><source>Biochem. Int.</source><year>1984</year><volume>9</volume><fpage>33</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">6477636</pub-id></element-citation></ref><ref id="B32-toxins-17-00264"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Samiee</surname><given-names>F.</given-names></name><name name-style="western"><surname>Kharazi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Elaridi</surname><given-names>J.</given-names></name><name name-style="western"><surname>Taravati Javad</surname><given-names>M.</given-names></name><name name-style="western"><surname>Leili</surname><given-names>M.</given-names></name></person-group><article-title>An assessment of the occurrence and nutritional factors associated with aflatoxin M1, ochratoxin A, and zearalenone in the breast milk of nursing mothers in Hamadan, Iran</article-title><source>Toxicon</source><year>2020</year><volume>187</volume><fpage>209</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2020.09.011</pub-id><pub-id pub-id-type="pmid">32971098</pub-id></element-citation></ref><ref id="B33-toxins-17-00264"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rezaei</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Hamzeh Pour</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ezati</surname><given-names>P.</given-names></name><name name-style="western"><surname>Akrami-Mohajeri</surname><given-names>F.</given-names></name></person-group><article-title>Determination of aflatoxin M1 and ochratoxin A in breast milk in rural centers of Yazd, Iran: Exposure assessment and risk characterization</article-title><source>Mycotoxin Res.</source><year>2024</year><volume>40</volume><fpage>211</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1007/s12550-024-00519-4</pub-id><pub-id pub-id-type="pmid">38285127</pub-id></element-citation></ref><ref id="B34-toxins-17-00264"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Das Trisha</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hafsa</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Hasan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Habib</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tuba</surname><given-names>H.R.</given-names></name><name name-style="western"><surname>Degen</surname><given-names>G.H.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>N.</given-names></name></person-group><article-title>Occurrence of ochratoxin A in breast milk and urine samples of nursing mothers in Bangladesh</article-title><source>Mycotoxin Res.</source><year>2024</year><volume>40</volume><fpage>135</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1007/s12550-023-00510-5</pub-id><pub-id pub-id-type="pmid">38038834</pub-id><pub-id pub-id-type="pmcid">PMC10834631</pub-id></element-citation></ref><ref id="B35-toxins-17-00264"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Dohnal</surname><given-names>V.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kuca</surname><given-names>K.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>G.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>Z.</given-names></name></person-group><article-title>Metabolic Pathways of Ochratoxin A</article-title><source>Curr. Drug Metab.</source><year>2011</year><volume>12</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.2174/138920011794520026</pub-id><pub-id pub-id-type="pmid">21222585</pub-id></element-citation></ref><ref id="B36-toxins-17-00264"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simarro Doorten</surname><given-names>A.Y.</given-names></name><name name-style="western"><surname>Bull</surname><given-names>S.</given-names></name><name name-style="western"><surname>van der Doelen</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Fink-Gremmels</surname><given-names>J.</given-names></name></person-group><article-title>Metabolism-mediated cytotoxicity of ochratoxin A</article-title><source>Toxicol. Vitro</source><year>2004</year><volume>18</volume><fpage>271</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1016/j.tiv.2003.10.001</pub-id><pub-id pub-id-type="pmid">15046773</pub-id></element-citation></ref><ref id="B37-toxins-17-00264"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knasmuller</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cavin</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chakraborty</surname><given-names>A.</given-names></name><name name-style="western"><surname>Darroudi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Majer</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Huber</surname><given-names>W.W.</given-names></name><name name-style="western"><surname>Ehrlich</surname><given-names>V.A.</given-names></name></person-group><article-title>Structurally Related Mycotoxins Ochratoxin A, Ochratoxin B, and Citrinin Differ in Their Genotoxic Activities and in Their Mode of Action in Human-Derived Liver (HepG2) Cells: Implications for Risk Assessment</article-title><source>Nutr. Cancer</source><year>2004</year><volume>50</volume><fpage>190</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1207/s15327914nc5002_9</pub-id><pub-id pub-id-type="pmid">15623466</pub-id></element-citation></ref><ref id="B38-toxins-17-00264"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Groh</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Geueke</surname><given-names>B.</given-names></name><name name-style="western"><surname>Muncke</surname><given-names>J.</given-names></name></person-group><article-title>Food contact materials and gut health: Implications for toxicity assessment and relevance of high molecular weight migrants</article-title><source>Food Chem. Toxicol.</source><year>2017</year><volume>109</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2017.08.023</pub-id><pub-id pub-id-type="pmid">28830834</pub-id></element-citation></ref><ref id="B39-toxins-17-00264"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Natividad</surname><given-names>J.M.M.</given-names></name><name name-style="western"><surname>Verdu</surname><given-names>E.F.</given-names></name></person-group><article-title>Modulation of intestinal barrier by intestinal microbiota: Pathological and therapeutic implications</article-title><source>Pharmacol. Res.</source><year>2013</year><volume>69</volume><fpage>42</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2012.10.007</pub-id><pub-id pub-id-type="pmid">23089410</pub-id></element-citation></ref><ref id="B40-toxins-17-00264"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Odenwald</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Turner</surname><given-names>J.R.</given-names></name></person-group><article-title>The intestinal epithelial barrier: A therapeutic target?</article-title><source>Nat. Rev. Gastroenterol. Hepatol.</source><year>2017</year><volume>14</volume><fpage>9</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1038/nrgastro.2016.169</pub-id><pub-id pub-id-type="pmid">27848962</pub-id><pub-id pub-id-type="pmcid">PMC5554468</pub-id></element-citation></ref><ref id="B41-toxins-17-00264"><label>41.</label><element-citation publication-type="webpage"><article-title>Crossing the Intestinal Barrier via Listeria Adhesion Protein and Internalin A: Trends in Microbiology</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cell.com/trends/microbiology/abstract/S0966-842X(18)30283-X?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0966842X1830283X%3Fshowall%3Dtrue" ext-link-type="uri">https://www.cell.com/trends/microbiology/abstract/S0966-842X(18)30283-X?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0966842X1830283X%3Fshowall%3Dtrue</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-03-26">(accessed on 26 March 2025)</date-in-citation><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tim.2018.12.007</pub-id><pub-id pub-id-type="pmid">30661918</pub-id></element-citation></ref><ref id="B42-toxins-17-00264"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>A.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Z.</given-names></name><name name-style="western"><surname>He</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name></person-group><article-title>A mitochondria-mediated apoptotic pathway induced by deoxynivalenol in human colon cancer cells</article-title><source>Toxicol. Vitro</source><year>2012</year><volume>26</volume><fpage>414</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1016/j.tiv.2012.01.010</pub-id><pub-id pub-id-type="pmid">22269384</pub-id></element-citation></ref><ref id="B43-toxins-17-00264"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonz&#225;lez-Mariscal</surname><given-names>L.</given-names></name><name name-style="western"><surname>Betanzos</surname><given-names>A.</given-names></name><name name-style="western"><surname>&#193;vila-Flores</surname><given-names>A.</given-names></name></person-group><article-title>MAGUK proteins: Structure and role in the tight junction</article-title><source>Semin. Cell Dev. Biol.</source><year>2000</year><volume>11</volume><fpage>315</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1006/scdb.2000.0178</pub-id><pub-id pub-id-type="pmid">10966866</pub-id></element-citation></ref><ref id="B44-toxins-17-00264"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Furuse</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hirase</surname><given-names>T.</given-names></name><name name-style="western"><surname>Itoh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nagafuchi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Yonemura</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tsukita</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tsukita</surname><given-names>S.</given-names></name></person-group><article-title>Occludin: A novel integral membrane protein localizing at tight junctions</article-title><source>J. Cell Biol.</source><year>1993</year><volume>123</volume><fpage>1777</fpage><lpage>1788</lpage><pub-id pub-id-type="doi">10.1083/jcb.123.6.1777</pub-id><pub-id pub-id-type="pmid">8276896</pub-id><pub-id pub-id-type="pmcid">PMC2290891</pub-id></element-citation></ref><ref id="B45-toxins-17-00264"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Meng</surname><given-names>L.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>N.</given-names></name></person-group><article-title>The Compromised Intestinal Barrier Induced by Mycotoxins</article-title><source>Toxins</source><year>2020</year><volume>12</volume><elocation-id>619</elocation-id><pub-id pub-id-type="doi">10.3390/toxins12100619</pub-id><pub-id pub-id-type="pmid">32998222</pub-id><pub-id pub-id-type="pmcid">PMC7600953</pub-id></element-citation></ref><ref id="B46-toxins-17-00264"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berg</surname><given-names>R.D.</given-names></name></person-group><article-title>Mechanisms confining indigenous bacteria to the gastrointestinal tract</article-title><source>Am. J. Clin. Nutr.</source><year>1980</year><volume>33</volume><issue>(Suppl. S11)</issue><fpage>2472</fpage><lpage>2484</lpage><pub-id pub-id-type="doi">10.1093/ajcn/33.11.2472</pub-id><pub-id pub-id-type="pmid">6449144</pub-id></element-citation></ref><ref id="B47-toxins-17-00264"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Inoue</surname><given-names>S.</given-names></name><name name-style="western"><surname>Epstein</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Alexander</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Trocki</surname><given-names>O.</given-names></name><name name-style="western"><surname>Jacobs</surname><given-names>P.</given-names></name><name name-style="western"><surname>Gura</surname><given-names>P.</given-names></name></person-group><article-title>Prevention of yeast translocation across the gut by a single enteral feeding after burn injury</article-title><source>JPEN J. Parenter. Enteral Nutr.</source><year>1989</year><volume>13</volume><fpage>565</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1177/0148607189013006565</pub-id><pub-id pub-id-type="pmid">2515302</pub-id></element-citation></ref><ref id="B48-toxins-17-00264"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bjarnason</surname><given-names>I.</given-names></name><name name-style="western"><surname>MacPherson</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hollander</surname><given-names>D.</given-names></name></person-group><article-title>Intestinal permeability: An overview</article-title><source>Gastroenterology</source><year>1995</year><volume>108</volume><fpage>1566</fpage><lpage>1581</lpage><pub-id pub-id-type="doi">10.1016/0016-5085(95)90708-4</pub-id><pub-id pub-id-type="pmid">7729650</pub-id></element-citation></ref><ref id="B49-toxins-17-00264"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khoi</surname><given-names>C.-S.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.-H.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>T.-Y.</given-names></name><name name-style="western"><surname>Chiang</surname><given-names>C.-K.</given-names></name><name name-style="western"><surname>Hung</surname><given-names>K.-Y.</given-names></name></person-group><article-title>Ochratoxin A-Induced Nephrotoxicity: Up-to-Date Evidence</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><elocation-id>11237</elocation-id><pub-id pub-id-type="doi">10.3390/ijms222011237</pub-id><pub-id pub-id-type="pmid">34681895</pub-id><pub-id pub-id-type="pmcid">PMC8539333</pub-id></element-citation></ref><ref id="B50-toxins-17-00264"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maresca</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mahfoud</surname><given-names>R.</given-names></name><name name-style="western"><surname>Pfohl-Leszkowicz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fantini</surname><given-names>J.</given-names></name></person-group><article-title>The mycotoxin ochratoxin A alters intestinal barrier and absorption functions but has no effect on chloride secretion</article-title><source>Toxicol. Appl. Pharmacol.</source><year>2001</year><volume>176</volume><fpage>54</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1006/taap.2001.9254</pub-id><pub-id pub-id-type="pmid">11578148</pub-id></element-citation></ref><ref id="B51-toxins-17-00264"><label>51.</label><element-citation publication-type="webpage"><article-title>The Intestinal Barrier as an Emerging Target in the Toxicological Assessment of Mycotoxins|Archives of Toxicology</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://link.springer.com/article/10.1007/s00204-016-1794-8" ext-link-type="uri">https://link.springer.com/article/10.1007/s00204-016-1794-8</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-03-26">(accessed on 26 March 2025)</date-in-citation><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00204-016-1794-8</pub-id><pub-id pub-id-type="pmcid">PMC5316402</pub-id><pub-id pub-id-type="pmid">27417439</pub-id></element-citation></ref><ref id="B52-toxins-17-00264"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McLaughlin</surname><given-names>J.</given-names></name><name name-style="western"><surname>Padfield</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Burt</surname><given-names>J.P.H.</given-names></name><name name-style="western"><surname>O&#8217;Neill</surname><given-names>C.A.</given-names></name></person-group><article-title>Ochratoxin A increases permeability through tight junctions by removal of specific claudin isoforms</article-title><source>Am. J. Physiol. Cell Physiol.</source><year>2004</year><volume>287</volume><fpage>C1412</fpage><lpage>C1417</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00007.2004</pub-id><pub-id pub-id-type="pmid">15229101</pub-id></element-citation></ref><ref id="B53-toxins-17-00264"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>N.</given-names></name></person-group><article-title>Modulation of Intestinal Epithelial Permeability in Differentiated Caco-2 Cells Exposed to Aflatoxin M1 and Ochratoxin A Individually or Collectively</article-title><source>Toxins</source><year>2017</year><volume>10</volume><elocation-id>13</elocation-id><pub-id pub-id-type="doi">10.3390/toxins10010013</pub-id><pub-id pub-id-type="pmid">29280945</pub-id><pub-id pub-id-type="pmcid">PMC5793100</pub-id></element-citation></ref><ref id="B54-toxins-17-00264"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Bao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>N.</given-names></name></person-group><article-title>Modulation of intestinal epithelial permeability and mucin mRNA (MUC2, MUC5AC, and MUC5B) expression and protein secretion in Caco-2/HT29-MTX co-cultures exposed to aflatoxin M1, ochratoxin A, and zearalenone individually or collectively</article-title><source>Toxicol. Lett.</source><year>2019</year><volume>309</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.toxlet.2019.03.010</pub-id><pub-id pub-id-type="pmid">30904571</pub-id></element-citation></ref><ref id="B55-toxins-17-00264"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Lv</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name></person-group><article-title>Selenomethionine attenuates ochratoxin A-induced small intestinal injury in rabbits by activating the Nrf2 pathway and inhibiting NF-&#954;B activation</article-title><source>Ecotoxicol. Environ. Saf.</source><year>2023</year><volume>256</volume><fpage>114837</fpage><pub-id pub-id-type="doi">10.1016/j.ecoenv.2023.114837</pub-id><pub-id pub-id-type="pmid">37001190</pub-id></element-citation></ref><ref id="B56-toxins-17-00264"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abbott</surname><given-names>N.J.</given-names></name><name name-style="western"><surname>Patabendige</surname><given-names>A.A.K.</given-names></name><name name-style="western"><surname>Dolman</surname><given-names>D.E.M.</given-names></name><name name-style="western"><surname>Yusof</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Begley</surname><given-names>D.J.</given-names></name></person-group><article-title>Structure and function of the blood-brain barrier</article-title><source>Neurobiol. Dis.</source><year>2010</year><volume>37</volume><fpage>13</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2009.07.030</pub-id><pub-id pub-id-type="pmid">19664713</pub-id></element-citation></ref><ref id="B57-toxins-17-00264"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Tran</surname><given-names>N.D.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>W.</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>M.J.</given-names></name></person-group><article-title>Brain endothelial hemostasis regulation by pericytes</article-title><source>J. Cereb. Blood Flow Metab.</source><year>2006</year><volume>26</volume><fpage>209</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1038/sj.jcbfm.9600181</pub-id><pub-id pub-id-type="pmid">16015279</pub-id></element-citation></ref><ref id="B58-toxins-17-00264"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cardoso</surname><given-names>F.L.</given-names></name><name name-style="western"><surname>Brites</surname><given-names>D.</given-names></name><name name-style="western"><surname>Brito</surname><given-names>M.A.</given-names></name></person-group><article-title>Looking at the blood-brain barrier: Molecular anatomy and possible investigation approaches</article-title><source>Brain Res. Rev.</source><year>2010</year><volume>64</volume><fpage>328</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1016/j.brainresrev.2010.05.003</pub-id><pub-id pub-id-type="pmid">20685221</pub-id></element-citation></ref><ref id="B59-toxins-17-00264"><label>59.</label><element-citation publication-type="webpage"><article-title>Cholesterol Metabolism in Neurons and Astrocytes&#8212;ScienceDirect</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.sciencedirect.com/science/article/abs/pii/S0163782711000312?via%3Dihub" ext-link-type="uri">https://www.sciencedirect.com/science/article/abs/pii/S0163782711000312?via%3Dihub</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-03-27">(accessed on 27 March 2025)</date-in-citation></element-citation></ref><ref id="B60-toxins-17-00264"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erceg</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mateo</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Zipancic</surname><given-names>I.</given-names></name><name name-style="western"><surname>Rodr&#237;guez Jim&#233;nez</surname><given-names>F.J.</given-names></name><name name-style="western"><surname>P&#233;rez Arag&#243;</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Jim&#233;nez</surname><given-names>M.</given-names></name><name name-style="western"><surname>Soria</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Garcia-Esparza</surname><given-names>M.&#193;.</given-names></name></person-group><article-title>Assessment of Toxic Effects of Ochratoxin A in Human Embryonic Stem Cells</article-title><source>Toxins</source><year>2019</year><volume>11</volume><elocation-id>217</elocation-id><pub-id pub-id-type="doi">10.3390/toxins11040217</pub-id><pub-id pub-id-type="pmid">30974856</pub-id><pub-id pub-id-type="pmcid">PMC6521021</pub-id></element-citation></ref><ref id="B61-toxins-17-00264"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mateo</surname><given-names>E.</given-names></name><name name-style="western"><surname>Tonino</surname><given-names>R.P.B.</given-names></name><name name-style="western"><surname>Canto</surname><given-names>A.</given-names></name><name name-style="western"><surname>Monroy Noyola</surname><given-names>A.</given-names></name><name name-style="western"><surname>Miranda</surname><given-names>M.</given-names></name><name name-style="western"><surname>Soria</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Garcia Esparza</surname><given-names>M.A.</given-names></name></person-group><article-title>The Neurotoxic Effect of Ochratoxin-A on the Hippocampal Neurogenic Niche of Adult Mouse Brain</article-title><source>Toxins</source><year>2022</year><volume>14</volume><elocation-id>624</elocation-id><pub-id pub-id-type="doi">10.3390/toxins14090624</pub-id><pub-id pub-id-type="pmid">36136561</pub-id><pub-id pub-id-type="pmcid">PMC9501519</pub-id></element-citation></ref><ref id="B62-toxins-17-00264"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Babayan</surname><given-names>N.</given-names></name><name name-style="western"><surname>Tadevosyan</surname><given-names>G.</given-names></name><name name-style="western"><surname>Khondkaryan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Grigoryan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sarkisyan</surname><given-names>N.</given-names></name><name name-style="western"><surname>Haroutiounian</surname><given-names>R.</given-names></name><name name-style="western"><surname>Stopper</surname><given-names>H.</given-names></name></person-group><article-title>Ochratoxin A induces global DNA hypomethylation and oxidative stress in neuronal cells in vitro</article-title><source>Mycotoxin Res.</source><year>2020</year><volume>36</volume><fpage>73</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1007/s12550-019-00370-y</pub-id><pub-id pub-id-type="pmid">31441013</pub-id></element-citation></ref><ref id="B63-toxins-17-00264"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sas</surname><given-names>K.</given-names></name><name name-style="western"><surname>Robotka</surname><given-names>H.</given-names></name><name name-style="western"><surname>Toldi</surname><given-names>J.</given-names></name><name name-style="western"><surname>V&#233;csei</surname><given-names>L.</given-names></name></person-group><article-title>Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders</article-title><source>J. Neurol. Sci.</source><year>2007</year><volume>257</volume><fpage>221</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1016/j.jns.2007.01.033</pub-id><pub-id pub-id-type="pmid">17462670</pub-id></element-citation></ref><ref id="B64-toxins-17-00264"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fukui</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hoshino</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kameyama</surname><given-names>Y.</given-names></name></person-group><article-title>Developmental abnormalities of mouse cerebellum induced by intracisternal injection of ochratoxin A in neonatal period</article-title><source>Exp. Neurol.</source><year>1987</year><volume>98</volume><fpage>54</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/0014-4886(87)90071-9</pub-id><pub-id pub-id-type="pmid">3653334</pub-id></element-citation></ref><ref id="B65-toxins-17-00264"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Behrens</surname><given-names>M.</given-names></name><name name-style="western"><surname>H&#252;wel</surname><given-names>S.</given-names></name><name name-style="western"><surname>Galla</surname><given-names>H.-J.</given-names></name><name name-style="western"><surname>Humpf</surname><given-names>H.-U.</given-names></name></person-group><article-title>Efflux at the Blood-Brain Barrier Reduces the Cerebral Exposure to Ochratoxin A, Ochratoxin &#945;, Citrinin and Dihydrocitrinone</article-title><source>Toxins</source><year>2021</year><volume>13</volume><elocation-id>327</elocation-id><pub-id pub-id-type="doi">10.3390/toxins13050327</pub-id><pub-id pub-id-type="pmid">33946578</pub-id><pub-id pub-id-type="pmcid">PMC8147254</pub-id></element-citation></ref><ref id="B66-toxins-17-00264"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pei</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Li</surname><given-names>D.</given-names></name></person-group><article-title>Food-Origin Mycotoxin-Induced Neurotoxicity: Intend to Break the Rules of Neuroglia Cells</article-title><source>Oxid. Med. Cell. Longev.</source><year>2021</year><volume>2021</volume><fpage>9967334</fpage><pub-id pub-id-type="doi">10.1155/2021/9967334</pub-id><pub-id pub-id-type="pmid">34621467</pub-id><pub-id pub-id-type="pmcid">PMC8492254</pub-id></element-citation></ref><ref id="B67-toxins-17-00264"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Napoli</surname><given-names>C.</given-names></name><name name-style="western"><surname>Marcotrigiano</surname><given-names>V.</given-names></name><name name-style="western"><surname>Pagliarone</surname><given-names>C.N.</given-names></name><name name-style="western"><surname>Montagna</surname><given-names>M.T.</given-names></name></person-group><article-title>Mycotoxins in food: Legislation and thresholds</article-title><source>Ig. E Sanita Pubblica</source><year>2009</year><volume>65</volume><fpage>607</fpage><lpage>620</lpage><pub-id pub-id-type="pmid">20376161</pub-id></element-citation></ref><ref id="B68-toxins-17-00264"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhat</surname><given-names>P.V.</given-names></name><name name-style="western"><surname>Pandareesh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Khanum</surname><given-names>F.</given-names></name><name name-style="western"><surname>Tamatam</surname><given-names>A.</given-names></name></person-group><article-title>Cytotoxic Effects of Ochratoxin A in Neuro-2a Cells: Role of Oxidative Stress Evidenced by N-acetylcysteine</article-title><source>Front. Microbiol.</source><year>2016</year><volume>7</volume><elocation-id>1142</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2016.01142</pub-id><pub-id pub-id-type="pmid">27531992</pub-id><pub-id pub-id-type="pmcid">PMC4969303</pub-id></element-citation></ref><ref id="B69-toxins-17-00264"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoon</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cong</surname><given-names>W.-T.</given-names></name><name name-style="western"><surname>Bang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.N.</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Kwack</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>T.S.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>K.Y.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>J.-K.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>H.J.</given-names></name></person-group><article-title>Proteome response to ochratoxin A-induced apoptotic cell death in mouse hippocampal HT22 cells</article-title><source>Neurotoxicology</source><year>2009</year><volume>30</volume><fpage>666</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1016/j.neuro.2009.04.013</pub-id><pub-id pub-id-type="pmid">19445961</pub-id></element-citation></ref><ref id="B70-toxins-17-00264"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sava</surname><given-names>V.</given-names></name><name name-style="western"><surname>Velasquez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Song</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sanchez-Ramos</surname><given-names>J.</given-names></name></person-group><article-title>Adult hippocampal neural stem/progenitor cells in vitro are vulnerable to the mycotoxin ochratoxin-A</article-title><source>Toxicol. Sci.</source><year>2007</year><volume>98</volume><fpage>187</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1093/toxsci/kfm093</pub-id><pub-id pub-id-type="pmid">17449898</pub-id></element-citation></ref><ref id="B71-toxins-17-00264"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hayes</surname><given-names>A.W.</given-names></name><name name-style="western"><surname>Hood</surname><given-names>R.D.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H.L.</given-names></name></person-group><article-title>Teratogenic effects of ochratoxin A in mice</article-title><source>Teratology</source><year>1974</year><volume>9</volume><fpage>93</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1002/tera.1420090112</pub-id><pub-id pub-id-type="pmid">4204660</pub-id></element-citation></ref><ref id="B72-toxins-17-00264"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sava</surname><given-names>V.</given-names></name><name name-style="western"><surname>Reunova</surname><given-names>O.</given-names></name><name name-style="western"><surname>Velasquez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Harbison</surname><given-names>R.</given-names></name><name name-style="western"><surname>S&#225;nchez-Ramos</surname><given-names>J.</given-names></name></person-group><article-title>Acute neurotoxic effects of the fungal metabolite ochratoxin-A</article-title><source>Neurotoxicology</source><year>2006</year><volume>27</volume><fpage>82</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.neuro.2005.07.004</pub-id><pub-id pub-id-type="pmid">16140385</pub-id></element-citation></ref><ref id="B73-toxins-17-00264"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sava</surname><given-names>V.</given-names></name><name name-style="western"><surname>Reunova</surname><given-names>O.</given-names></name><name name-style="western"><surname>Velasquez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sanchez-Ramos</surname><given-names>J.</given-names></name></person-group><article-title>Can low level exposure to ochratoxin-A cause parkinsonism?</article-title><source>J. Neurol. Sci.</source><year>2006</year><volume>249</volume><fpage>68</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.jns.2006.06.006</pub-id><pub-id pub-id-type="pmid">16844142</pub-id></element-citation></ref><ref id="B74-toxins-17-00264"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hong</surname><given-names>J.T.</given-names></name><name name-style="western"><surname>Park</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Han</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Park</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Oh</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>R.D.</given-names></name><name name-style="western"><surname>Jang</surname><given-names>S.J.</given-names></name></person-group><article-title>Effects of ochratoxin A on cytotoxicity and cell differentiation in cultured rat embryonic cells</article-title><source>J. Toxicol. Environ. Health A</source><year>2000</year><volume>61</volume><fpage>609</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1080/00984100050194126</pub-id><pub-id pub-id-type="pmid">11127415</pub-id></element-citation></ref><ref id="B75-toxins-17-00264"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wangikar</surname><given-names>P.B.</given-names></name><name name-style="western"><surname>Dwivedi</surname><given-names>P.</given-names></name><name name-style="western"><surname>Sinha</surname><given-names>N.</given-names></name></person-group><article-title>Effect in rats of simultaneous prenatal exposure to ochratoxin A and aflatoxin B1. I. Maternal toxicity and fetal malformations</article-title><source>Birth Defects Res. B. Dev. Reprod. Toxicol.</source><year>2004</year><volume>71</volume><fpage>343</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1002/bdrb.20021</pub-id><pub-id pub-id-type="pmid">15617020</pub-id></element-citation></ref><ref id="B76-toxins-17-00264"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Niaz</surname><given-names>K.</given-names></name><name name-style="western"><surname>Shah</surname><given-names>S.Z.A.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bule</surname><given-names>M.</given-names></name></person-group><article-title>Ochratoxin A-induced genotoxic and epigenetic mechanisms lead to Alzheimer disease: Its modulation with strategies</article-title><source>Environ. Sci. Pollut. Res.</source><year>2020</year><volume>27</volume><fpage>44673</fpage><lpage>44700</lpage><pub-id pub-id-type="doi">10.1007/s11356-020-08991-y</pub-id><pub-id pub-id-type="pmid">32424756</pub-id></element-citation></ref><ref id="B77-toxins-17-00264"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ratnaseelan</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Tsilioni</surname><given-names>I.</given-names></name><name name-style="western"><surname>Theoharides</surname><given-names>T.C.</given-names></name></person-group><article-title>Effects of Mycotoxins on Neuropsychiatric Symptoms and Immune Processes</article-title><source>Clin. Ther.</source><year>2018</year><volume>40</volume><fpage>903</fpage><lpage>917</lpage><pub-id pub-id-type="doi">10.1016/j.clinthera.2018.05.004</pub-id><pub-id pub-id-type="pmid">29880330</pub-id></element-citation></ref><ref id="B78-toxins-17-00264"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>W.</given-names></name><name name-style="western"><surname>You</surname><given-names>S.</given-names></name><name name-style="western"><surname>Song</surname><given-names>G.</given-names></name></person-group><article-title>Ochratoxin A exerts neurotoxicity in human astrocytes through mitochondria-dependent apoptosis and intracellular calcium overload</article-title><source>Toxicol. Lett.</source><year>2019</year><volume>313</volume><fpage>42</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.toxlet.2019.05.021</pub-id><pub-id pub-id-type="pmid">31154016</pub-id></element-citation></ref><ref id="B79-toxins-17-00264"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Izco</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vettorazzi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Forcen</surname><given-names>R.</given-names></name><name name-style="western"><surname>Blesa</surname><given-names>J.</given-names></name><name name-style="western"><surname>de Toro</surname><given-names>M.</given-names></name><name name-style="western"><surname>Alvarez-Herrera</surname><given-names>N.</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Gonzalez-Pe&#241;as</surname><given-names>E.</given-names></name><name name-style="western"><surname>Lopez de Cerain</surname><given-names>A.</given-names></name><name name-style="western"><surname>Alvarez-Erviti</surname><given-names>L.</given-names></name></person-group><article-title>Oral subchronic exposure to the mycotoxin ochratoxin A induces key pathological features of Parkinson&#8217;s disease in mice six months after the end of the treatment</article-title><source>Food Chem. Toxicol.</source><year>2021</year><volume>152</volume><fpage>112164</fpage><pub-id pub-id-type="doi">10.1016/j.fct.2021.112164</pub-id><pub-id pub-id-type="pmid">33819549</pub-id></element-citation></ref><ref id="B80-toxins-17-00264"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhat</surname><given-names>P.V.</given-names></name><name name-style="western"><surname>Anand</surname><given-names>T.</given-names></name><name name-style="western"><surname>Mohan Manu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Khanum</surname><given-names>F.</given-names></name></person-group><article-title>Restorative effect of l-Dopa treatment against Ochratoxin A induced neurotoxicity</article-title><source>Neurochem. Int.</source><year>2018</year><volume>118</volume><fpage>252</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2018.04.003</pub-id><pub-id pub-id-type="pmid">29627381</pub-id></element-citation></ref><ref id="B81-toxins-17-00264"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Santis</surname><given-names>B.</given-names></name><name name-style="western"><surname>Brera</surname><given-names>C.</given-names></name><name name-style="western"><surname>Mezzelani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Soricelli</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ciceri</surname><given-names>F.</given-names></name><name name-style="western"><surname>Moretti</surname><given-names>G.</given-names></name><name name-style="western"><surname>Debegnach</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bonaglia</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Villa</surname><given-names>L.</given-names></name><name name-style="western"><surname>Molteni</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Role of mycotoxins in the pathobiology of autism: A first evidence</article-title><source>Nutr. Neurosci.</source><year>2019</year><volume>22</volume><fpage>132</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1080/1028415X.2017.1357793</pub-id><pub-id pub-id-type="pmid">28795659</pub-id></element-citation></ref><ref id="B82-toxins-17-00264"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mezzelani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Raggi</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Marabotti</surname><given-names>A.</given-names></name><name name-style="western"><surname>Milanesi</surname><given-names>L.</given-names></name></person-group><article-title>Ochratoxin A as possible factor trigging autism and its male prevalence via epigenetic mechanism</article-title><source>Nutr. Neurosci.</source><year>2016</year><volume>19</volume><fpage>43</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1179/1476830515Z.000000000186</pub-id><pub-id pub-id-type="pmid">25597866</pub-id></element-citation></ref><ref id="B83-toxins-17-00264"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sorrenti</surname><given-names>V.</given-names></name><name name-style="western"><surname>Di Giacomo</surname><given-names>C.</given-names></name><name name-style="western"><surname>Acquaviva</surname><given-names>R.</given-names></name><name name-style="western"><surname>Barbagallo</surname><given-names>I.</given-names></name><name name-style="western"><surname>Bognanno</surname><given-names>M.</given-names></name><name name-style="western"><surname>Galvano</surname><given-names>F.</given-names></name></person-group><article-title>Toxicity of ochratoxin a and its modulation by antioxidants: A review</article-title><source>Toxins</source><year>2013</year><volume>5</volume><fpage>1742</fpage><lpage>1766</lpage><pub-id pub-id-type="doi">10.3390/toxins5101742</pub-id><pub-id pub-id-type="pmid">24152986</pub-id><pub-id pub-id-type="pmcid">PMC3813909</pub-id></element-citation></ref><ref id="B84-toxins-17-00264"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gautier</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Holzhaeuser</surname><given-names>D.</given-names></name><name name-style="western"><surname>Markovic</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gremaud</surname><given-names>E.</given-names></name><name name-style="western"><surname>Schilter</surname><given-names>B.</given-names></name><name name-style="western"><surname>Turesky</surname><given-names>R.J.</given-names></name></person-group><article-title>Oxidative damage and stress response from ochratoxin a exposure in rats</article-title><source>Free Radic. Biol. Med.</source><year>2001</year><volume>30</volume><fpage>1089</fpage><lpage>1098</lpage><pub-id pub-id-type="doi">10.1016/S0891-5849(01)00507-X</pub-id><pub-id pub-id-type="pmid">11369498</pub-id></element-citation></ref><ref id="B85-toxins-17-00264"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mally</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pepe</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ravoori</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fiore</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Dekant</surname><given-names>W.</given-names></name><name name-style="western"><surname>Mosesso</surname><given-names>P.</given-names></name></person-group><article-title>Ochratoxin a causes DNA damage and cytogenetic effects but no DNA adducts in rats</article-title><source>Chem. Res. Toxicol.</source><year>2005</year><volume>18</volume><fpage>1253</fpage><lpage>1261</lpage><pub-id pub-id-type="doi">10.1021/tx049650x</pub-id><pub-id pub-id-type="pmid">16097798</pub-id></element-citation></ref><ref id="B86-toxins-17-00264"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arbillaga</surname><given-names>L.</given-names></name><name name-style="western"><surname>Azqueta</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ezpeleta</surname><given-names>O.</given-names></name><name name-style="western"><surname>L&#243;pez de Cerain</surname><given-names>A.</given-names></name></person-group><article-title>Oxidative DNA damage induced by Ochratoxin A in the HK-2 human kidney cell line: Evidence of the relationship with cytotoxicity</article-title><source>Mutagenesis</source><year>2007</year><volume>22</volume><fpage>35</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1093/mutage/gel049</pub-id><pub-id pub-id-type="pmid">17130176</pub-id></element-citation></ref><ref id="B87-toxins-17-00264"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marin-Kuan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ehrlich</surname><given-names>V.</given-names></name><name name-style="western"><surname>Delatour</surname><given-names>T.</given-names></name><name name-style="western"><surname>Cavin</surname><given-names>C.</given-names></name><name name-style="western"><surname>Schilter</surname><given-names>B.</given-names></name></person-group><article-title>Evidence for a role of oxidative stress in the carcinogenicity of ochratoxin a</article-title><source>J. Toxicol.</source><year>2011</year><volume>2011</volume><fpage>645361</fpage><pub-id pub-id-type="doi">10.1155/2011/645361</pub-id><pub-id pub-id-type="pmid">21776264</pub-id><pub-id pub-id-type="pmcid">PMC3135259</pub-id></element-citation></ref><ref id="B88-toxins-17-00264"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prakash</surname><given-names>C.</given-names></name><name name-style="western"><surname>Soni</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>V.</given-names></name></person-group><article-title>Mitochondrial oxidative stress and dysfunction in arsenic neurotoxicity: A review</article-title><source>J. Appl. Toxicol.</source><year>2016</year><volume>36</volume><fpage>179</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1002/jat.3256</pub-id><pub-id pub-id-type="pmid">26510484</pub-id></element-citation></ref><ref id="B89-toxins-17-00264"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dash</surname><given-names>U.C.</given-names></name><name name-style="western"><surname>Bhol</surname><given-names>N.K.</given-names></name><name name-style="western"><surname>Swain</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Samal</surname><given-names>R.R.</given-names></name><name name-style="western"><surname>Nayak</surname><given-names>P.K.</given-names></name><name name-style="western"><surname>Raina</surname><given-names>V.</given-names></name><name name-style="western"><surname>Panda</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Kerry</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Duttaroy</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Jena</surname><given-names>A.B.</given-names></name></person-group><article-title>Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implications</article-title><source>Acta Pharm. Sin. B</source><year>2024</year><volume>15</volume><fpage>15</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.apsb.2024.10.004</pub-id><pub-id pub-id-type="pmid">40041912</pub-id><pub-id pub-id-type="pmcid">PMC11873663</pub-id></element-citation></ref><ref id="B90-toxins-17-00264"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uttara</surname><given-names>B.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>A.V.</given-names></name><name name-style="western"><surname>Zamboni</surname><given-names>P.</given-names></name><name name-style="western"><surname>Mahajan</surname><given-names>R.T.</given-names></name></person-group><article-title>Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options</article-title><source>Curr. Neuropharmacol.</source><year>2009</year><volume>7</volume><fpage>65</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.2174/157015909787602823</pub-id><pub-id pub-id-type="pmid">19721819</pub-id><pub-id pub-id-type="pmcid">PMC2724665</pub-id></element-citation></ref><ref id="B91-toxins-17-00264"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bedard</surname><given-names>K.</given-names></name><name name-style="western"><surname>Krause</surname><given-names>K.-H.</given-names></name></person-group><article-title>The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology</article-title><source>Physiol. Rev.</source><year>2007</year><volume>87</volume><fpage>245</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1152/physrev.00044.2005</pub-id><pub-id pub-id-type="pmid">17237347</pub-id></element-citation></ref><ref id="B92-toxins-17-00264"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kabe</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ando</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hirao</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>M.</given-names></name><name name-style="western"><surname>Handa</surname><given-names>H.</given-names></name></person-group><article-title>Redox regulation of NF-kappaB activation: Distinct redox regulation between the cytoplasm and the nucleus</article-title><source>Antioxid. Redox Signal.</source><year>2005</year><volume>7</volume><fpage>395</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1089/ars.2005.7.395</pub-id><pub-id pub-id-type="pmid">15706086</pub-id></element-citation></ref><ref id="B93-toxins-17-00264"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Battelli</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Polito</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bolognesi</surname><given-names>A.</given-names></name></person-group><article-title>Xanthine oxidoreductase in atherosclerosis pathogenesis: Not only oxidative stress</article-title><source>Atherosclerosis</source><year>2014</year><volume>237</volume><fpage>562</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2014.10.006</pub-id><pub-id pub-id-type="pmid">25463089</pub-id></element-citation></ref><ref id="B94-toxins-17-00264"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gandhi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Abramov</surname><given-names>A.Y.</given-names></name></person-group><article-title>Mechanism of oxidative stress in neurodegeneration</article-title><source>Oxid. Med. Cell. Longev.</source><year>2012</year><volume>2012</volume><fpage>428010</fpage><pub-id pub-id-type="doi">10.1155/2012/428010</pub-id><pub-id pub-id-type="pmid">22685618</pub-id><pub-id pub-id-type="pmcid">PMC3362933</pub-id></element-citation></ref><ref id="B95-toxins-17-00264"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>S.-J.</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>D.-G.</given-names></name><name name-style="western"><surname>Syed</surname><given-names>G.H.</given-names></name><name name-style="western"><surname>Siddiqui</surname><given-names>A.</given-names></name></person-group><article-title>The essential role of mitochondrial dynamics in antiviral immunity</article-title><source>Mitochondrion</source><year>2018</year><volume>41</volume><fpage>21</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.mito.2017.11.007</pub-id><pub-id pub-id-type="pmid">29246869</pub-id><pub-id pub-id-type="pmcid">PMC5988924</pub-id></element-citation></ref><ref id="B96-toxins-17-00264"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santos</surname><given-names>D.</given-names></name><name name-style="western"><surname>Esteves</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Silva</surname><given-names>D.F.</given-names></name><name name-style="western"><surname>Janu&#225;rio</surname><given-names>C.</given-names></name><name name-style="western"><surname>Cardoso</surname><given-names>S.M.</given-names></name></person-group><article-title>The Impact of Mitochondrial Fusion and Fission Modulation in Sporadic Parkinson&#8217;s Disease</article-title><source>Mol. Neurobiol.</source><year>2015</year><volume>52</volume><fpage>573</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1007/s12035-014-8893-4</pub-id><pub-id pub-id-type="pmid">25218511</pub-id></element-citation></ref><ref id="B97-toxins-17-00264"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bouaziz</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sharaf El Dein</surname><given-names>O.</given-names></name><name name-style="western"><surname>El Golli</surname><given-names>E.</given-names></name><name name-style="western"><surname>Abid-Essefi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Brenner</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lemaire</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bacha</surname><given-names>H.</given-names></name></person-group><article-title>Different apoptotic pathways induced by zearalenone, T-2 toxin and ochratoxin A in human hepatoma cells</article-title><source>Toxicology</source><year>2008</year><volume>254</volume><fpage>19</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.tox.2008.08.020</pub-id><pub-id pub-id-type="pmid">18834919</pub-id></element-citation></ref><ref id="B98-toxins-17-00264"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>Y.H.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>C.Y.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>T.N.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>R.D.</given-names></name></person-group><article-title>Effect of ochratoxin A on rat liver mitochondrial respiration and oxidative phosphorylation</article-title><source>Toxicology</source><year>1985</year><volume>36</volume><fpage>119</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1016/0300-483X(85)90046-0</pub-id><pub-id pub-id-type="pmid">2996181</pub-id></element-citation></ref><ref id="B99-toxins-17-00264"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>A.</given-names></name></person-group><article-title>Ochratoxin A induces mitochondrial dysfunction, oxidative stress, and apoptosis of retinal ganglion cells (RGCs), leading to retinal damage in mice</article-title><source>Int. Ophthalmol.</source><year>2024</year><volume>44</volume><fpage>72</fpage><pub-id pub-id-type="doi">10.1007/s10792-024-03032-w</pub-id><pub-id pub-id-type="pmid">38349605</pub-id><pub-id pub-id-type="pmcid">PMC10864473</pub-id></element-citation></ref><ref id="B100-toxins-17-00264"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ye</surname><given-names>M.-J.</given-names></name><name name-style="western"><surname>Meng</surname><given-names>N.</given-names></name></person-group><article-title>Resveratrol acts via the mitogen-activated protein kinase (MAPK) pathway to protect retinal ganglion cells from apoptosis induced by hydrogen peroxide</article-title><source>Bioengineered</source><year>2021</year><volume>12</volume><fpage>4878</fpage><lpage>4886</lpage><pub-id pub-id-type="doi">10.1080/21655979.2021.1954742</pub-id><pub-id pub-id-type="pmid">34374636</pub-id><pub-id pub-id-type="pmcid">PMC8806786</pub-id></element-citation></ref><ref id="B101-toxins-17-00264"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsilioni</surname><given-names>I.</given-names></name><name name-style="western"><surname>Theoharides</surname><given-names>T.C.</given-names></name></person-group><article-title>Ochratoxin A stimulates release of IL-1&#946;, IL&#8211;18 and CXCL8 from cultured human microglia</article-title><source>Toxicology</source><year>2024</year><volume>502</volume><fpage>153738</fpage><pub-id pub-id-type="doi">10.1016/j.tox.2024.153738</pub-id><pub-id pub-id-type="pmid">38301823</pub-id></element-citation></ref><ref id="B102-toxins-17-00264"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hickman</surname><given-names>S.</given-names></name><name name-style="western"><surname>Izzy</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sen</surname><given-names>P.</given-names></name><name name-style="western"><surname>Morsett</surname><given-names>L.</given-names></name><name name-style="western"><surname>El Khoury</surname><given-names>J.</given-names></name></person-group><article-title>Microglia in neurodegeneration</article-title><source>Nat. Neurosci.</source><year>2018</year><volume>21</volume><fpage>1359</fpage><lpage>1369</lpage><pub-id pub-id-type="doi">10.1038/s41593-018-0242-x</pub-id><pub-id pub-id-type="pmid">30258234</pub-id><pub-id pub-id-type="pmcid">PMC6817969</pub-id></element-citation></ref><ref id="B103-toxins-17-00264"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Umpierre</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>L.-J.</given-names></name></person-group><article-title>How microglia sense and regulate neuronal activity</article-title><source>Glia</source><year>2021</year><volume>69</volume><fpage>1637</fpage><lpage>1653</lpage><pub-id pub-id-type="doi">10.1002/glia.23961</pub-id><pub-id pub-id-type="pmid">33369790</pub-id><pub-id pub-id-type="pmcid">PMC8113084</pub-id></element-citation></ref><ref id="B104-toxins-17-00264"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Streit</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Conde</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Fendrick</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Flanary</surname><given-names>B.E.</given-names></name><name name-style="western"><surname>Mariani</surname><given-names>C.L.</given-names></name></person-group><article-title>Role of microglia in the central nervous system&#8217;s immune response</article-title><source>Neurol. Res.</source><year>2005</year><volume>27</volume><fpage>685</fpage><lpage>691</lpage><pub-id pub-id-type="doi">10.1179/016164105X49463a</pub-id><pub-id pub-id-type="pmid">16197805</pub-id></element-citation></ref><ref id="B105-toxins-17-00264"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arena</surname><given-names>G.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>K.</given-names></name><name name-style="western"><surname>Agyeah</surname><given-names>G.</given-names></name><name name-style="western"><surname>Kr&#252;ger</surname><given-names>R.</given-names></name><name name-style="western"><surname>Gr&#252;newald</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fitzgerald</surname><given-names>J.C.</given-names></name></person-group><article-title>Neurodegeneration and Neuroinflammation in Parkinson&#8217;s Disease: A Self-Sustained Loop</article-title><source>Curr. Neurol. Neurosci. Rep.</source><year>2022</year><volume>22</volume><fpage>427</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1007/s11910-022-01207-5</pub-id><pub-id pub-id-type="pmid">35674870</pub-id><pub-id pub-id-type="pmcid">PMC9174445</pub-id></element-citation></ref><ref id="B106-toxins-17-00264"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Monnet-Tschudi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zurich</surname><given-names>M.-G.</given-names></name><name name-style="western"><surname>Honegger</surname><given-names>P.</given-names></name></person-group><article-title>Neurotoxicant-induced inflammatory response in three-dimensional brain cell cultures</article-title><source>Hum. Exp. Toxicol.</source><year>2007</year><volume>26</volume><fpage>339</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1177/0960327107074589</pub-id><pub-id pub-id-type="pmid">17615115</pub-id></element-citation></ref><ref id="B107-toxins-17-00264"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Callaghan</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Sriram</surname><given-names>K.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>D.B.</given-names></name></person-group><article-title>Defining &#8220;neuroinflammation&#8221;</article-title><source>Ann. N. Y. Acad. Sci.</source><year>2008</year><volume>1139</volume><fpage>318</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1196/annals.1432.032</pub-id><pub-id pub-id-type="pmid">18991877</pub-id></element-citation></ref><ref id="B108-toxins-17-00264"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tremblay</surname><given-names>M.-&#200;.</given-names></name><name name-style="western"><surname>Lowery</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Majewska</surname><given-names>A.K.</given-names></name></person-group><article-title>Microglial interactions with synapses are modulated by visual experience</article-title><source>PLoS Biol.</source><year>2010</year><volume>8</volume><elocation-id>e1000527</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1000527</pub-id><pub-id pub-id-type="pmid">21072242</pub-id><pub-id pub-id-type="pmcid">PMC2970556</pub-id></element-citation></ref><ref id="B109-toxins-17-00264"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sellner</surname><given-names>S.</given-names></name><name name-style="western"><surname>Paricio-Montesinos</surname><given-names>R.</given-names></name><name name-style="western"><surname>Spie&#223;</surname><given-names>A.</given-names></name><name name-style="western"><surname>Masuch</surname><given-names>A.</given-names></name><name name-style="western"><surname>Erny</surname><given-names>D.</given-names></name><name name-style="western"><surname>Harsan</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Elverfeldt</surname><given-names>D.V.</given-names></name><name name-style="western"><surname>Schwabenland</surname><given-names>M.</given-names></name><name name-style="western"><surname>Biber</surname><given-names>K.</given-names></name><name name-style="western"><surname>Staszewski</surname><given-names>O.</given-names></name><etal/></person-group><article-title>Microglial CX3CR1 promotes adult neurogenesis by inhibiting Sirt 1/p65 signaling independent of CX3CL1</article-title><source>Acta Neuropathol. Commun.</source><year>2016</year><volume>4</volume><fpage>102</fpage><pub-id pub-id-type="doi">10.1186/s40478-016-0374-8</pub-id><pub-id pub-id-type="pmid">27639555</pub-id><pub-id pub-id-type="pmcid">PMC5027111</pub-id></element-citation></ref><ref id="B110-toxins-17-00264"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nimmerjahn</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kirchhoff</surname><given-names>F.</given-names></name><name name-style="western"><surname>Helmchen</surname><given-names>F.</given-names></name></person-group><article-title>Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo</article-title><source>Science</source><year>2005</year><volume>308</volume><fpage>1314</fpage><lpage>1318</lpage><pub-id pub-id-type="doi">10.1126/science.1110647</pub-id><pub-id pub-id-type="pmid">15831717</pub-id></element-citation></ref><ref id="B111-toxins-17-00264"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Monnet-Tschudi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Sorg</surname><given-names>O.</given-names></name><name name-style="western"><surname>Honegger</surname><given-names>P.</given-names></name><name name-style="western"><surname>Zurich</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Huggett</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Schilter</surname><given-names>B.</given-names></name></person-group><article-title>Effects of the naturally occurring food mycotoxin ochratoxin A on brain cells in culture</article-title><source>Neurotoxicology</source><year>1997</year><volume>18</volume><fpage>831</fpage><lpage>839</lpage><pub-id pub-id-type="pmid">9339829</pub-id></element-citation></ref><ref id="B112-toxins-17-00264"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zurich</surname><given-names>M.-G.</given-names></name><name name-style="western"><surname>Lengacher</surname><given-names>S.</given-names></name><name name-style="western"><surname>Braissant</surname><given-names>O.</given-names></name><name name-style="western"><surname>Monnet-Tschudi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Pellerin</surname><given-names>L.</given-names></name><name name-style="western"><surname>Honegger</surname><given-names>P.</given-names></name></person-group><article-title>Unusual astrocyte reactivity caused by the food mycotoxin ochratoxin A in aggregating rat brain cell cultures</article-title><source>Neuroscience</source><year>2005</year><volume>134</volume><fpage>771</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2005.04.030</pub-id><pub-id pub-id-type="pmid">15994020</pub-id></element-citation></ref><ref id="B113-toxins-17-00264"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eng</surname><given-names>L.F.</given-names></name><name name-style="western"><surname>Ghirnikar</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y.L.</given-names></name></person-group><article-title>Glial fibrillary acidic protein: GFAP-thirty-one years (1969&#8211;2000)</article-title><source>Neurochem. Res.</source><year>2000</year><volume>25</volume><fpage>1439</fpage><lpage>1451</lpage><pub-id pub-id-type="doi">10.1023/A:1007677003387</pub-id><pub-id pub-id-type="pmid">11059815</pub-id></element-citation></ref><ref id="B114-toxins-17-00264"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brenner</surname><given-names>M.</given-names></name></person-group><article-title>Structure and transcriptional regulation of the GFAP gene</article-title><source>Brain Pathol.</source><year>1994</year><volume>4</volume><fpage>245</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1111/j.1750-3639.1994.tb00840.x</pub-id><pub-id pub-id-type="pmid">7952266</pub-id></element-citation></ref><ref id="B115-toxins-17-00264"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tramontina</surname><given-names>F.</given-names></name><name name-style="western"><surname>Leite</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Cereser</surname><given-names>K.</given-names></name><name name-style="western"><surname>de Souza</surname><given-names>D.F.</given-names></name><name name-style="western"><surname>Tramontina</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Nardin</surname><given-names>P.</given-names></name><name name-style="western"><surname>Andreazza</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Gottfried</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kapczinski</surname><given-names>F.</given-names></name><name name-style="western"><surname>Gon&#231;alves</surname><given-names>C.-A.</given-names></name></person-group><article-title>Immunoassay for glial fibrillary acidic protein: Antigen recognition is affected by its phosphorylation state</article-title><source>J. Neurosci. Methods</source><year>2007</year><volume>162</volume><fpage>282</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1016/j.jneumeth.2007.01.001</pub-id><pub-id pub-id-type="pmid">17303248</pub-id></element-citation></ref><ref id="B116-toxins-17-00264"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rumora</surname><given-names>L.</given-names></name><name name-style="western"><surname>Grubi&#353;i&#263;</surname><given-names>T.</given-names></name></person-group><article-title>A Journey Through Mitogen-Activated Protein Kinase and Ochratoxin A Interactions</article-title><source>Arch. Ind. Hyg. Toxicol.</source><year>2009</year><volume>60</volume><fpage>449</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.2478/10004-1254-60-2009-1969</pub-id><pub-id pub-id-type="pmid">20061246</pub-id></element-citation></ref><ref id="B117-toxins-17-00264"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rumora</surname><given-names>L.</given-names></name><name name-style="western"><surname>Domijan</surname><given-names>A.-M.</given-names></name><name name-style="western"><surname>&#381;ani&#263; Grubi&#353;i&#263;</surname><given-names>T.</given-names></name><name name-style="western"><surname>&#352;egvi&#263; Klari&#263;</surname><given-names>M.</given-names></name></person-group><article-title>Differential activation of MAPKs by individual and combined ochratoxin A and citrinin treatments in porcine kidney PK15 cells</article-title><source>Toxicon</source><year>2014</year><volume>90</volume><fpage>174</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2014.08.006</pub-id><pub-id pub-id-type="pmid">25128707</pub-id></element-citation></ref><ref id="B118-toxins-17-00264"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koistinaho</surname><given-names>M.</given-names></name><name name-style="western"><surname>Koistinaho</surname><given-names>J.</given-names></name></person-group><article-title>Role of p38 and p44/42 mitogen-activated protein kinases in microglia</article-title><source>Glia</source><year>2002</year><volume>40</volume><fpage>175</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1002/glia.10151</pub-id><pub-id pub-id-type="pmid">12379905</pub-id></element-citation></ref><ref id="B119-toxins-17-00264"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chansawhang</surname><given-names>A.</given-names></name><name name-style="western"><surname>Phochantachinda</surname><given-names>S.</given-names></name><name name-style="western"><surname>Temviriyanukul</surname><given-names>P.</given-names></name><name name-style="western"><surname>Chantong</surname><given-names>B.</given-names></name></person-group><article-title>Corticosterone potentiates ochratoxin A-induced microglial activation</article-title><source>Biomol. Concepts</source><year>2022</year><volume>13</volume><fpage>230</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1515/bmc-2022-0017</pub-id><pub-id pub-id-type="pmid">35437979</pub-id></element-citation></ref><ref id="B120-toxins-17-00264"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Penalva-Olcina</surname><given-names>R.</given-names></name><name name-style="western"><surname>Juan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Fern&#225;ndez-Franz&#243;n</surname><given-names>M.</given-names></name><name name-style="western"><surname>Juan-Garc&#237;a</surname><given-names>A.</given-names></name></person-group><article-title>Involvement of pro-inflammatory mediators and cell cycle disruption in neuronal cells induced by gliotoxin and ochratoxin A after individual and combined exposure</article-title><source>Toxicol. Lett.</source><year>2024</year><volume>393</volume><fpage>24</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.toxlet.2024.01.009</pub-id><pub-id pub-id-type="pmid">38244709</pub-id></element-citation></ref><ref id="B121-toxins-17-00264"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>von Tobel</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Antinori</surname><given-names>P.</given-names></name><name name-style="western"><surname>Zurich</surname><given-names>M.-G.</given-names></name><name name-style="western"><surname>Rosset</surname><given-names>R.</given-names></name><name name-style="western"><surname>Aschner</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gl&#252;ck</surname><given-names>F.</given-names></name><name name-style="western"><surname>Scherl</surname><given-names>A.</given-names></name><name name-style="western"><surname>Monnet-Tschudi</surname><given-names>F.</given-names></name></person-group><article-title>Repeated exposure to Ochratoxin A generates a neuroinflammatory response, characterized by neurodegenerative M1 microglial phenotype</article-title><source>Neurotoxicology</source><year>2014</year><volume>44</volume><fpage>61</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.neuro.2014.04.005</pub-id><pub-id pub-id-type="pmid">24792326</pub-id></element-citation></ref><ref id="B122-toxins-17-00264"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bradl</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lassmann</surname><given-names>H.</given-names></name></person-group><article-title>Oligodendrocytes: Biology and pathology</article-title><source>Acta Neuropathol.</source><year>2010</year><volume>119</volume><fpage>37</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1007/s00401-009-0601-5</pub-id><pub-id pub-id-type="pmid">19847447</pub-id><pub-id pub-id-type="pmcid">PMC2799635</pub-id></element-citation></ref><ref id="B123-toxins-17-00264"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuhn</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gritti</surname><given-names>L.</given-names></name><name name-style="western"><surname>Crooks</surname><given-names>D.</given-names></name><name name-style="western"><surname>Dombrowski</surname><given-names>Y.</given-names></name></person-group><article-title>Oligodendrocytes in Development, Myelin Generation and Beyond</article-title><source>Cells</source><year>2019</year><volume>8</volume><elocation-id>1424</elocation-id><pub-id pub-id-type="doi">10.3390/cells8111424</pub-id><pub-id pub-id-type="pmid">31726662</pub-id><pub-id pub-id-type="pmcid">PMC6912544</pub-id></element-citation></ref><ref id="B124-toxins-17-00264"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kempuraj</surname><given-names>D.</given-names></name><name name-style="western"><surname>Dourvetakis</surname><given-names>K.D.</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Valladares</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Joshi</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Kothuru</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>T.</given-names></name><name name-style="western"><surname>Chinnappan</surname><given-names>B.</given-names></name><name name-style="western"><surname>Cheema</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Klimas</surname><given-names>N.G.</given-names></name><etal/></person-group><article-title>Neurovascular unit, neuroinflammation and neurodegeneration markers in brain disorders</article-title><source>Front. Cell. Neurosci.</source><year>2024</year><volume>18</volume><elocation-id>1491952</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2024.1491952</pub-id><pub-id pub-id-type="pmid">39526043</pub-id><pub-id pub-id-type="pmcid">PMC11544127</pub-id></element-citation></ref><ref id="B125-toxins-17-00264"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tilleux</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hermans</surname><given-names>E.</given-names></name></person-group><article-title>Neuroinflammation and regulation of glial glutamate uptake in neurological disorders</article-title><source>J. Neurosci. Res.</source><year>2007</year><volume>85</volume><fpage>2059</fpage><lpage>2070</lpage><pub-id pub-id-type="doi">10.1002/jnr.21325</pub-id><pub-id pub-id-type="pmid">17497670</pub-id></element-citation></ref><ref id="B126-toxins-17-00264"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Razafimanjato</surname><given-names>H.</given-names></name><name name-style="western"><surname>Garmy</surname><given-names>N.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>X.-J.</given-names></name><name name-style="western"><surname>Varini</surname><given-names>K.</given-names></name><name name-style="western"><surname>Di Scala</surname><given-names>C.</given-names></name><name name-style="western"><surname>Di Pasquale</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ta&#239;eb</surname><given-names>N.</given-names></name><name name-style="western"><surname>Maresca</surname><given-names>M.</given-names></name></person-group><article-title>The food-associated fungal neurotoxin ochratoxin A inhibits the absorption of glutamate by astrocytes through a decrease in cell surface expression of the excitatory amino-acid transporters GLAST and GLT-1</article-title><source>NeuroToxicology</source><year>2010</year><volume>31</volume><fpage>475</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1016/j.neuro.2010.06.003</pub-id><pub-id pub-id-type="pmid">20558201</pub-id></element-citation></ref><ref id="B127-toxins-17-00264"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miranda</surname><given-names>M.</given-names></name><name name-style="western"><surname>Morici</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Zanoni</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Bekinschtein</surname><given-names>P.</given-names></name></person-group><article-title>Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain</article-title><source>Front. Cell. Neurosci.</source><year>2019</year><volume>13</volume><elocation-id>363</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2019.00363</pub-id><pub-id pub-id-type="pmid">31440144</pub-id><pub-id pub-id-type="pmcid">PMC6692714</pub-id></element-citation></ref><ref id="B128-toxins-17-00264"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sferra</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nicita</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bertini</surname><given-names>E.</given-names></name></person-group><article-title>Microtubule Dysfunction: A Common Feature of Neurodegenerative Diseases</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>7354</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21197354</pub-id><pub-id pub-id-type="pmid">33027950</pub-id><pub-id pub-id-type="pmcid">PMC7582320</pub-id></element-citation></ref><ref id="B129-toxins-17-00264"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>R.</given-names></name><name name-style="western"><surname>Gettings</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Hazell</surname><given-names>G.</given-names></name><name name-style="western"><surname>Bourbia</surname><given-names>N.</given-names></name></person-group><article-title>In vitro study of ochratoxin A in the expression of genes associated with neuron survival and viability</article-title><source>Toxicology</source><year>2023</year><volume>483</volume><fpage>153376</fpage><pub-id pub-id-type="doi">10.1016/j.tox.2022.153376</pub-id><pub-id pub-id-type="pmid">36400265</pub-id></element-citation></ref><ref id="B130-toxins-17-00264"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D&#8217;Ascenzo</surname><given-names>M.</given-names></name><name name-style="western"><surname>Colussi</surname><given-names>C.</given-names></name></person-group><article-title>Oxidative Stress and the Central Nervous System</article-title><source>Antioxidants</source><year>2025</year><volume>14</volume><elocation-id>110</elocation-id><pub-id pub-id-type="doi">10.3390/antiox14010110</pub-id><pub-id pub-id-type="pmid">39857444</pub-id><pub-id pub-id-type="pmcid">PMC11762381</pub-id></element-citation></ref><ref id="B131-toxins-17-00264"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Magistretti</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Allaman</surname><given-names>I.</given-names></name></person-group><article-title>A cellular perspective on brain energy metabolism and functional imaging</article-title><source>Neuron</source><year>2015</year><volume>86</volume><fpage>883</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2015.03.035</pub-id><pub-id pub-id-type="pmid">25996133</pub-id></element-citation></ref><ref id="B132-toxins-17-00264"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cobley</surname><given-names>J.N.</given-names></name><name name-style="western"><surname>Fiorello</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>D.M.</given-names></name></person-group><article-title>13 reasons why the brain is susceptible to oxidative stress</article-title><source>Redox Biol.</source><year>2018</year><volume>15</volume><fpage>490</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2018.01.008</pub-id><pub-id pub-id-type="pmid">29413961</pub-id><pub-id pub-id-type="pmcid">PMC5881419</pub-id></element-citation></ref><ref id="B133-toxins-17-00264"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>K.H.</given-names></name><name name-style="western"><surname>Cha</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>B.H.</given-names></name></person-group><article-title>Neuroprotective Effect of Antioxidants in the Brain</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>7152</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21197152</pub-id><pub-id pub-id-type="pmid">32998277</pub-id><pub-id pub-id-type="pmcid">PMC7582347</pub-id></element-citation></ref><ref id="B134-toxins-17-00264"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grabska-Koby&#322;ecka</surname><given-names>I.</given-names></name><name name-style="western"><surname>Szpakowski</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kr&#243;l</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ksi&#261;&#380;ek-Winiarek</surname><given-names>D.</given-names></name><name name-style="western"><surname>Koby&#322;ecki</surname><given-names>A.</given-names></name><name name-style="western"><surname>G&#322;&#261;bi&#324;ski</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nowak</surname><given-names>D.</given-names></name></person-group><article-title>Polyphenols and Their Impact on the Prevention of Neurodegenerative Diseases and Development</article-title><source>Nutrients</source><year>2023</year><volume>15</volume><elocation-id>3454</elocation-id><pub-id pub-id-type="doi">10.3390/nu15153454</pub-id><pub-id pub-id-type="pmid">37571391</pub-id><pub-id pub-id-type="pmcid">PMC10420887</pub-id></element-citation></ref><ref id="B135-toxins-17-00264"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miyazawa</surname><given-names>T.</given-names></name><name name-style="western"><surname>Burdeos</surname><given-names>G.C.</given-names></name><name name-style="western"><surname>Itaya</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nakagawa</surname><given-names>K.</given-names></name><name name-style="western"><surname>Miyazawa</surname><given-names>T.</given-names></name></person-group><article-title>Vitamin E: Regulatory Redox Interactions</article-title><source>IUBMB Life</source><year>2019</year><volume>71</volume><fpage>430</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1002/iub.2008</pub-id><pub-id pub-id-type="pmid">30681767</pub-id></element-citation></ref><ref id="B136-toxins-17-00264"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>da Cunha Germano</surname><given-names>B.C.</given-names></name><name name-style="western"><surname>de Morais</surname><given-names>L.C.C.</given-names></name><name name-style="western"><surname>Idalina Neta</surname><given-names>F.</given-names></name><name name-style="western"><surname>Fernandes</surname><given-names>A.C.L.</given-names></name><name name-style="western"><surname>Pinheiro</surname><given-names>F.I.</given-names></name><name name-style="western"><surname>do Rego</surname><given-names>A.C.M.</given-names></name><name name-style="western"><surname>Ara&#250;jo Filho</surname><given-names>I.</given-names></name><name name-style="western"><surname>de Azevedo</surname><given-names>E.P.</given-names></name><name name-style="western"><surname>de Paiva Cavalcanti</surname><given-names>J.R.L.</given-names></name><name name-style="western"><surname>Guzen</surname><given-names>F.P.</given-names></name><etal/></person-group><article-title>Vitamin E and Its Molecular Effects in Experimental Models of Neurodegenerative Diseases</article-title><source>Int. J. Mol. Sci.</source><year>2023</year><volume>24</volume><elocation-id>11191</elocation-id><pub-id pub-id-type="doi">10.3390/ijms241311191</pub-id><pub-id pub-id-type="pmid">37446369</pub-id><pub-id pub-id-type="pmcid">PMC10342514</pub-id></element-citation></ref><ref id="B137-toxins-17-00264"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boothby</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Doering</surname><given-names>P.L.</given-names></name></person-group><article-title>Vitamin C and vitamin E for Alzheimer&#8217;s disease</article-title><source>Ann. Pharmacother.</source><year>2005</year><volume>39</volume><fpage>2073</fpage><lpage>2080</lpage><pub-id pub-id-type="doi">10.1345/aph.1E495</pub-id><pub-id pub-id-type="pmid">16227450</pub-id></element-citation></ref><ref id="B138-toxins-17-00264"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gorres</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Raines</surname><given-names>R.T.</given-names></name></person-group><article-title>Prolyl 4-hydroxylase</article-title><source>Crit. Rev. Biochem. Mol. Biol.</source><year>2010</year><volume>45</volume><fpage>106</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.3109/10409231003627991</pub-id><pub-id pub-id-type="pmid">20199358</pub-id><pub-id pub-id-type="pmcid">PMC2841224</pub-id></element-citation></ref><ref id="B139-toxins-17-00264"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muroyama</surname><given-names>A.</given-names></name></person-group><article-title>An alternative medical approach for the neuroprotective therapy to slow the progression of Parkinson&#8217;s disease</article-title><source>Yakugaku Zasshi</source><year>2013</year><volume>133</volume><fpage>849</fpage><lpage>856</lpage><pub-id pub-id-type="doi">10.1248/yakushi.13-00158</pub-id><pub-id pub-id-type="pmid">23903224</pub-id></element-citation></ref><ref id="B140-toxins-17-00264"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>H.W.</given-names></name><name name-style="western"><surname>Park</surname><given-names>C.G.</given-names></name><name name-style="western"><surname>Park</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Park</surname><given-names>H.R.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>J.</given-names></name><name name-style="western"><surname>Paek</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Choy</surname><given-names>Y.B.</given-names></name></person-group><article-title>Intrastriatal administration of coenzyme Q10 enhances neuroprotection in a Parkinson&#8217;s disease rat model</article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><elocation-id>9572</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-66493-w</pub-id><pub-id pub-id-type="pmid">32533070</pub-id><pub-id pub-id-type="pmcid">PMC7293316</pub-id></element-citation></ref><ref id="B141-toxins-17-00264"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korczowska-&#321;&#261;cka</surname><given-names>I.</given-names></name><name name-style="western"><surname>S&#322;owikowski</surname><given-names>B.</given-names></name><name name-style="western"><surname>Piekut</surname><given-names>T.</given-names></name><name name-style="western"><surname>Hur&#322;a</surname><given-names>M.</given-names></name><name name-style="western"><surname>Banaszek</surname><given-names>N.</given-names></name><name name-style="western"><surname>Szymanowicz</surname><given-names>O.</given-names></name><name name-style="western"><surname>Jagodzi&#324;ski</surname><given-names>P.P.</given-names></name><name name-style="western"><surname>Kozubski</surname><given-names>W.</given-names></name><name name-style="western"><surname>Permoda-Pachuta</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dorszewska</surname><given-names>J.</given-names></name></person-group><article-title>Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases</article-title><source>Antioxidants</source><year>2023</year><volume>12</volume><elocation-id>1811</elocation-id><pub-id pub-id-type="doi">10.3390/antiox12101811</pub-id><pub-id pub-id-type="pmid">37891890</pub-id><pub-id pub-id-type="pmcid">PMC10604347</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="toxins-17-00264-f001" orientation="portrait"><label>Figure 1</label><caption><p>Chemical structure of ochratoxin.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="toxins-17-00264-g001.jpg"/></fig><fig position="float" id="toxins-17-00264-f002" orientation="portrait"><label>Figure 2</label><caption><p>Ochratoxin A analogues.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="toxins-17-00264-g002.jpg"/></fig><fig position="float" id="toxins-17-00264-f003" orientation="portrait"><label>Figure 3</label><caption><p>Hydroxylated derivatives (4-OH-OTA and 10-OH-OTA) from OTA and conjugation products with glutathione.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="toxins-17-00264-g003.jpg"/></fig><fig position="float" id="toxins-17-00264-f004" orientation="portrait"><label>Figure 4</label><caption><p>The maintenance of normal gut equilibrium relies on a four-tiered defense system against external challenges. This system incorporates a physical component (a single layer of epithelial cells with selective permeability), a chemical component (a mucus layer containing mucins and antimicrobial peptides, released by goblet and Paneth cells, respectively), an immunological component (immune cells residing within the lamina propria and secreted immune signaling molecules like cytokines and secretory immunoglobulin A [sIgA]), and a microbial component (the community of commensal bacteria within the intestinal lumen). Adjacent epithelial cells are joined by tight junctions, complex structures of transmembrane proteins such as junctional adhesion molecules (JAMs), claudins, and occludin, which are anchored to the actin cytoskeleton via zonula occludens (ZO) proteins (adapted from [<xref rid="B45-toxins-17-00264" ref-type="bibr">45</xref>]).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="toxins-17-00264-g004.jpg"/></fig><fig position="float" id="toxins-17-00264-f005" orientation="portrait"><label>Figure 5</label><caption><p>(<bold>A</bold>): Mycotoxins exert detrimental effects on the gut barrier through several key mechanisms. These include (i) elevated permeability, affecting both paracellular and transcellular transport pathways, which arises from damage to epithelial cells and tight junctions, and (ii) a reduction in the thickness of the mucus layer. This compromised gut barrier allows for the entry of foreign substances of varying molecular sizes and the movement of bacteria across the intestinal lining, ultimately contributing to a disruption of the balance in inflammatory conditions (adapted from [<xref rid="B45-toxins-17-00264" ref-type="bibr">45</xref>]). (<bold>B</bold>): Mycotoxins originating from food sources can induce damage to neurons and the brain by affecting astrocytes and microglia. Mycotoxins, such as ochratoxin A (OTA), primarily enter the body via contaminated crops and foods derived from animals (including meat, eggs, milk, sugarcane, and edible offal). Both mycotoxins and their breakdown products can readily cross the blood&#8211;brain barrier (BBB) and affect astrocytes and microglia, potentially leading to neuronal and brain damage. The question of whether mycotoxins contribute to neurodegenerative diseases, such as Alzheimer&#8217;s, Parkinson&#8217;s, Huntington&#8217;s, and amyotrophic lateral sclerosis, requires further investigation (adapted from [<xref rid="B66-toxins-17-00264" ref-type="bibr">66</xref>]).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="toxins-17-00264-g005.jpg"/></fig><fig position="float" id="toxins-17-00264-f006" orientation="portrait"><label>Figure 6</label><caption><p>Brain mouse affected areas. (<bold>A</bold>), caudoputamen, Yoon et al. (2009) [<xref rid="B68-toxins-17-00264" ref-type="bibr">68</xref>] and Sas (2007) [<xref rid="B63-toxins-17-00264" ref-type="bibr">63</xref>]; (<bold>B</bold>), cerebellum, (<bold>C</bold>), cortex frontalis, Sas (2007) [<xref rid="B63-toxins-17-00264" ref-type="bibr">63</xref>]; (<bold>D</bold>), hippocampus, Mateo et al. (2022) [<xref rid="B61-toxins-17-00264" ref-type="bibr">61</xref>], Yoon et al. (2009) [<xref rid="B68-toxins-17-00264" ref-type="bibr">68</xref>] and Sava et al. (2007) [<xref rid="B69-toxins-17-00264" ref-type="bibr">69</xref>]; (<bold>E</bold>), striatum, Sas (2007) [<xref rid="B63-toxins-17-00264" ref-type="bibr">63</xref>]; (<bold>F</bold>), substantia nigra, Sas (2007) [<xref rid="B63-toxins-17-00264" ref-type="bibr">63</xref>]; (<bold>G</bold>), subventricular zone (SVZ), Paradells et al. (2015) [<xref rid="B5-toxins-17-00264" ref-type="bibr">5</xref>]; Sas (2007) [<xref rid="B63-toxins-17-00264" ref-type="bibr">63</xref>]; Modified from Allen Mouse Brain Atlas [dataset], Allen Institute for Brain Science (2011). The red line shows the affected anatomical structure.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="toxins-17-00264-g006.jpg"/></fig></floats-group></article></pmc-articleset>